// Auto-generated tree configuration with metadata
export const treeConfig = {
  "name": "dfda-wiki",
  "type": "directory",
  "path": ".",
  "children": [
    {
      "name": "01-problem.md",
      "type": "file",
      "path": "01-problem.md",
      "children": [],
      "metadata": {
        "description": "You and Everyone You Love Will Suffer and Die.",
        "emoji": "üíÄ",
        "title": "Problems We Can Solve with a Decentralized FDA",
        "number": "150k",
        "textFollowingNumber": "people die every day from possibly preventable degenerative diseases",
        "tags": "global-health, chronic-diseases, preventable-deaths, healthcare-spending",
        "published": true,
        "editor": "markdown",
        "date": "2025-02-11T13:38:21.578Z",
        "dateCreated": "2025-02-11T13:38:21.578Z"
      }
    },
    {
      "name": "02-solution.md",
      "type": "file",
      "path": "02-solution.md",
      "children": [],
      "metadata": {
        "description": "How we reduce suffering using a decentralized autonomous organization as a vehicle to use the oceans of real-world evidence to discover new cures.",
        "emoji": "üéØ",
        "title": "Personalized Precision Medicine Framework",
        "tags": "precision-medicine, insilico-models, machine-learning, genomics, transcriptomics, proteomics, metabolomics, microbiomics, phenotype",
        "published": true,
        "editor": "markdown",
        "date": "2025-02-11T14:02:49.420Z",
        "dateCreated": "2025-02-11T14:02:49.420Z"
      }
    },
    {
      "name": "03-platform.md",
      "type": "file",
      "path": "03-platform.md",
      "children": [],
      "metadata": {
        "title": "üè≠ Platform",
        "description": "A detailed description of the core open-source platform and plugin framework that will enable the transformation of data into clinical discoveries.",
        "published": true,
        "date": "2025-02-18T05:14:54.240Z",
        "tags": "clinical-trials, health-data, decentralization, digital-health, interoperability, ehr-systems",
        "editor": "markdown",
        "dateCreated": "2023-11-07T19:01:19.907Z"
      }
    },
    {
      "name": "SITEMAP.md",
      "type": "file",
      "path": "SITEMAP.md",
      "children": [],
      "metadata": {
        "title": "DFDA Wiki Sitemap",
        "description": "Comprehensive navigation structure for the DFDA Wiki",
        "lastUpdated": "2024-02-09",
        "status": "live"
      }
    },
    {
      "name": "benefits",
      "type": "directory",
      "path": "benefits",
      "children": [
        {
          "name": "cost-savings-from-decentralized-clinical-trials.md",
          "type": "file",
          "path": "benefits/cost-savings-from-decentralized-clinical-trials.md",
          "children": [],
          "metadata": {
            "description": "Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors",
            "emoji": "üåç",
            "title": "Cost Savings from Decentralized Clinical Trials",
            "tags": "decentralized-clinical-trials, cost-savings, financial-benefits, trial-timelines",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-11T15:30:36.846Z",
            "dateCreated": "2025-02-11T15:30:36.847Z"
          }
        },
        {
          "name": "faster-progress.md",
          "type": "file",
          "path": "benefits/faster-progress.md",
          "children": [],
          "metadata": {
            "number": "20X",
            "textFollowingNumber": "the rate of treatment discovery",
            "title": "20X the Speed of Curing Diseases",
            "description": "By reducing the cost of clinical trials by 95%, we can run 20 times more trials with the same resources, dramatically accelerating the discovery of new treatments and cures.",
            "emoji": "üöÄ",
            "featuredImage": "cost-per-participant.jpg",
            "source": "https://dfda.earth#cost-savings",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-09T16:20:32.118Z",
            "dateCreated": "2025-02-09T16:20:32.118Z"
          }
        },
        {
          "name": "improving-treatment-affordability-and-accessibility.md",
          "type": "file",
          "path": "benefits/improving-treatment-affordability-and-accessibility.md",
          "children": [],
          "metadata": {
            "description": "How the proposed decentralized FDA system could dramatically improve affordability and accessibility of treatments for patients through cost reductions, price competition, and faster access",
            "emoji": "üí∞",
            "title": "Improving Treatment Affordability and Accessibility",
            "tags": "affordability, accessibility, drug-prices, cost-reduction, patient-benefits",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-15T14:30:00.236Z",
            "dateCreated": "2025-02-15T14:30:00.236Z"
          }
        },
        {
          "name": "lower-costs-of-validated-observational-research-for-efficacy.md",
          "type": "file",
          "path": "benefits/lower-costs-of-validated-observational-research-for-efficacy.md",
          "children": [],
          "metadata": {
            "description": "Observational real-world evidence-based studies have several advantages over randomized, controlled trials, including lower cost, increased speed of research, and a broader range of patients.",
            "emoji": "üëÄ",
            "title": "Lower Costs of Validated Observational Research for Efficacy",
            "tags": "observational-research, cost-effectiveness, real-world-evidence, meta-analyses, clinical-studies",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T15:32:45.179Z",
            "dateCreated": "2025-02-12T15:32:45.179Z"
          }
        },
        {
          "name": "lower-costs.md",
          "type": "file",
          "path": "benefits/lower-costs.md",
          "children": [],
          "metadata": {
            "number": "95%",
            "textFollowingNumber": "lower costs of clinical trials and treatments",
            "title": "95% Lower Costs of Clinical Trials and Treatments",
            "description": "By automating clinical trials and treatments, we can reduce costs by 95%",
            "emoji": "üìâ",
            "featuredImage": "cost-per-participant.jpg",
            "source": "https://dfda.earth#cost-savings",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-09T16:20:32.127Z",
            "dateCreated": "2025-02-09T16:20:32.127Z"
          }
        },
        {
          "name": "lower-drug-prices.md",
          "type": "file",
          "path": "benefits/lower-drug-prices.md",
          "children": [],
          "metadata": {
            "title": "Lower Drug Prices",
            "description": "Below is a deeper quantitative analysis of how drastically cheaper trials and increased competition (including off-patent/unpatentable compounds) could push drug prices down.",
            "emoji": "ü§ë",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-09T16:20:32.129Z",
            "dateCreated": "2025-02-09T16:20:32.129Z"
          }
        },
        {
          "name": "more-cures-and-less-lifelong-attempts-at-masking-symptoms.md",
          "type": "file",
          "path": "benefits/more-cures-and-less-lifelong-attempts-at-masking-symptoms.md",
          "children": [],
          "metadata": {
            "description": "High Costs Punish Finding Cures Over Masking Symptoms Since Cures Are Far Less Profitable Than Lifetime Treatments",
            "emoji": "üí∞",
            "title": "Economic Incentives for Medical Cures vs Symptom Management",
            "tags": "medical-economics, drug-development, cures, symptom-management, R&D",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T15:33:40.236Z",
            "dateCreated": "2025-02-12T15:33:40.236Z"
          }
        },
        {
          "name": "overall-economic-benefits.md",
          "type": "file",
          "path": "benefits/overall-economic-benefits.md",
          "children": [],
          "metadata": {
            "title": "Overall Economic Benefits",
            "description": "Quantitative analysis of global economic benefits from decentralized clinical trials and automated FDA processes",
            "emoji": "üìà",
            "toc": true,
            "published": true,
            "editor": "markdown",
            "date": "2025-02-09T16:20:32.132Z",
            "dateCreated": "2025-02-09T16:20:32.132Z"
          }
        },
        {
          "name": "patient-participation.md",
          "type": "file",
          "path": "benefits/patient-participation.md",
          "children": [],
          "metadata": {
            "number": "100%",
            "textFollowingNumber": "of patients can participate in trials",
            "title": "100% Patient Participation in Trials",
            "description": "By removing traditional barriers and using decentralized trials, we can include the 100% of patients typically excluded from clinical research",
            "emoji": "üåç",
            "featuredImage": "patient-participation.jpg",
            "source": "https://dfda.earth",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-09T16:20:32.136Z",
            "dateCreated": "2025-02-09T16:20:32.136Z"
          }
        },
        {
          "name": "time-to-treatment.md",
          "type": "file",
          "path": "benefits/time-to-treatment.md",
          "children": [],
          "metadata": {
            "number": "2 Years",
            "textFollowingNumber": "instead of 17 years to get new treatments to patients",
            "title": "17 years to 2 Year From Research to Treatment",
            "description": "By streamlining the clinical trial process through automation and decentralization, we can reduce the time from initial research to patient availability from 17 years to just 2 years",
            "emoji": "‚ö°",
            "featuredImage": "treatment-time.jpg",
            "source": "https://dfda.earth",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-09T16:20:32.141Z",
            "dateCreated": "2025-02-09T16:20:32.141Z"
          }
        }
      ]
    },
    {
      "name": "blueprint",
      "type": "directory",
      "path": "blueprint",
      "children": [
        {
          "name": "blueprint-gas.md",
          "type": "file",
          "path": "blueprint/blueprint-gas.md",
          "children": [],
          "metadata": {
            "description": "A system of incentivized actions to promote the adoption of a global blueprint, including rewards for optimizing the blueprint and generating public support.",
            "emoji": "ü§ù",
            "title": "Incentivized Actions for Global Blueprint Adoption",
            "tags": "global-blueprint, incentives, public-support, blueprint-optimization",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:46:56.763Z",
            "dateCreated": "2025-02-12T16:46:56.763Z"
          }
        },
        {
          "name": "blueprint-high-level.md",
          "type": "file",
          "path": "blueprint/blueprint-high-level.md",
          "children": [],
          "metadata": {
            "description": "A framework for envisioning and implementing a world without disease, including defining the ideal, creating a roadmap, seeking global consent, and enacting legal reforms.",
            "emoji": "üåç",
            "title": "Framework for a World Without Disease",
            "tags": "disease-eradication, global-health, policy, framework",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:47:32.477Z",
            "dateCreated": "2025-02-12T16:47:32.477Z"
          }
        },
        {
          "name": "blueprint-sitemap.md",
          "type": "file",
          "path": "blueprint/blueprint-sitemap.md",
          "children": [],
          "metadata": {
            "description": "A proposal to shift healthcare focus from treating diseases to preventing and curing them, with a plan involving global participation and legislative change.",
            "emoji": "üåç",
            "title": "Blueprint for a World Without Disease",
            "tags": "healthcare-reform, disease-prevention, global-initiatives, public-health",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:50:24.919Z",
            "dateCreated": "2025-02-12T16:50:24.919Z"
          }
        },
        {
          "name": "blueprint-strategy.md",
          "type": "file",
          "path": "blueprint/blueprint-strategy.md",
          "children": [],
          "metadata": {
            "description": "A strategy for reducing disease by collecting global health data, empowering patient choice, incentivizing cures, and involving all stakeholders.",
            "emoji": "üåç",
            "title": "Strategy for a World Without Disease",
            "tags": "global-health, data-collection, patient-empowerment, disease-prevention, healthcare-innovation",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:50:31.159Z",
            "dateCreated": "2025-02-12T16:50:31.159Z"
          }
        },
        {
          "name": "blueprint-summary.md",
          "type": "file",
          "path": "blueprint/blueprint-summary.md",
          "children": [],
          "metadata": {
            "description": "An overview of the unnecessary suffering caused by current healthcare and regulatory systems, highlighting specific examples of preventable pain and disease.",
            "emoji": "üö´",
            "title": "Creating a World Without Disease",
            "tags": "healthcare, regulatory-systems, disease-prevention, FDA",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:50:53.964Z",
            "dateCreated": "2025-02-12T16:50:53.964Z"
          }
        },
        {
          "name": "blueprint.md",
          "type": "file",
          "path": "blueprint/blueprint.md",
          "children": [],
          "metadata": {
            "description": "Analysis of the preventable suffering caused by systemic issues in healthcare and drug development",
            "emoji": "ü©∫",
            "title": "Creating a World Without Disease",
            "tags": "healthcare, drug-development, regulatory-system, disease-prevention",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:51:17.425Z",
            "dateCreated": "2025-02-12T16:51:17.425Z"
          }
        }
      ]
    },
    {
      "name": "clinical-trials",
      "type": "directory",
      "path": "clinical-trials",
      "children": [
        {
          "name": "decentralized-methods",
          "type": "directory",
          "path": "clinical-trials/decentralized-methods",
          "children": [
            {
              "name": "desci-ai-dao.md",
              "type": "file",
              "path": "clinical-trials/decentralized-methods/desci-ai-dao.md",
              "children": [],
              "metadata": {
                "title": "DeSci DAO AI Agent Framework",
                "description": "How to create a truly autonomous DAO that actually accelerates scientific progress",
                "published": true,
                "date": "2023-07-23T19:59:32.942Z",
                "tags": "dao, ai, automation, desci",
                "editor": "markdown",
                "dateCreated": "2023-07-22T20:42:01.243Z"
              }
            }
          ]
        },
        {
          "name": "methodologies",
          "type": "directory",
          "path": "clinical-trials/methodologies",
          "children": [
            {
              "name": "definitions.md",
              "type": "file",
              "path": "clinical-trials/methodologies/definitions.md",
              "children": [],
              "metadata": {
                "description": "Precise definitions of relevant terms used",
                "emoji": "üìö",
                "title": "üìñKey Definitions",
                "tags": "healthcare, interventions, efficacy, effectiveness, definitions",
                "published": true,
                "editor": "markdown",
                "date": "2022-07-26T02:40:33.718Z",
                "dateCreated": "2022-07-22T19:05:03.787Z"
              }
            }
          ]
        },
        {
          "name": "protocols",
          "type": "directory",
          "path": "clinical-trials/protocols",
          "children": [
            {
              "name": "crowdsourcing-longevity-research.md",
              "type": "file",
              "path": "clinical-trials/protocols/crowdsourcing-longevity-research.md",
              "children": [],
              "metadata": {
                "title": "Experimental Protocol for Crowdsourcing Longevity Research",
                "description": "An experimental protocol for crowdsourcing longevity research for a random intervention and collecting outcome data to characterize the participant's overall health status using affordable and valuable collection methods",
                "published": true,
                "date": "2023-06-21T04:49:22.560Z",
                "tags": "longevity, experimental protocols",
                "editor": "markdown",
                "dateCreated": "2023-06-21T04:49:22.560Z"
              }
            }
          ]
        }
      ]
    },
    {
      "name": "community",
      "type": "directory",
      "path": "community",
      "children": [
        {
          "name": "CONTRIBUTING.md",
          "type": "file",
          "path": "community/CONTRIBUTING.md",
          "children": [],
          "metadata": {
            "description": "Guidelines for contributing to the Community Directory, including steps for getting started and making contributions via pull requests.",
            "emoji": "ü§ù",
            "title": "Contributing to the Community Directory",
            "tags": "dFDA, community-directory, contributing, open-source",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:51:44.377Z",
            "dateCreated": "2025-02-12T16:51:44.377Z"
          }
        },
        {
          "name": "README.md",
          "type": "file",
          "path": "community/README.md",
          "children": [],
          "metadata": {
            "description": "A directory to facilitate collaboration among stakeholders in the project",
            "emoji": "üë•",
            "title": "Community Directory",
            "tags": "dFDA, community, collaboration, decentralized-health, regulatory-processes",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:52:13.974Z",
            "dateCreated": "2025-02-12T16:52:13.974Z"
          }
        },
        {
          "name": "community_volunteers",
          "type": "directory",
          "path": "community/community_volunteers",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/community_volunteers/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for community volunteers contributing to the project, providing resources and guidance for involvement.",
                "emoji": "ü§ù",
                "title": "Community Volunteers Directory",
                "tags": "volunteers, community, contribution",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:51:40.444Z",
                "dateCreated": "2025-02-12T16:51:40.444Z"
              }
            }
          ]
        },
        {
          "name": "developers",
          "type": "directory",
          "path": "community/developers",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/developers/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for developers, data scientists, and AI experts contributing to the technical development of the project.",
                "emoji": "üíª",
                "title": "Developers Directory",
                "tags": "developers, software, data-science, AI, community",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:51:47.494Z",
                "dateCreated": "2025-02-12T16:51:47.494Z"
              }
            }
          ]
        },
        {
          "name": "funding_sources",
          "type": "directory",
          "path": "community/funding_sources",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/funding_sources/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for funding sources interested in supporting initiatives within the project, providing information on funding opportunities and facilitating connections between funders and project teams.",
                "emoji": "üí∞",
                "title": "Funding Sources Directory",
                "tags": "funding, investors, philanthropy, grants",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:51:51.033Z",
                "dateCreated": "2025-02-12T16:51:51.033Z"
              }
            }
          ]
        },
        {
          "name": "governance",
          "type": "directory",
          "path": "community/governance",
          "children": [
            {
              "name": "dfda-collaboration-framework.md",
              "type": "file",
              "path": "community/governance/dfda-collaboration-framework.md",
              "children": [],
              "metadata": {
                "description": "A coordination framework for facilitating cooperation, communication, and collaborative actions among stakeholders in clinical discovery and health outcomes.",
                "emoji": "ü§ù",
                "title": "dFDA Collaboration Framework",
                "tags": "coordination-framework, clinical-discovery, stakeholder-collaboration, health-outcomes",
                "published": true,
                "editor": "markdown",
                "date": "2023-10-28T22:44:51.813Z",
                "dateCreated": "2023-10-28T22:42:49.138Z"
              }
            }
          ]
        },
        {
          "name": "healthcare_providers",
          "type": "directory",
          "path": "community/healthcare_providers",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/healthcare_providers/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for healthcare providers including hospitals, clinics, and health apps involved in the project",
                "emoji": "üè•",
                "title": "Healthcare Providers Directory",
                "tags": "healthcare-providers, community-directory, collaboration",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:51:55.194Z",
                "dateCreated": "2025-02-12T16:51:55.194Z"
              }
            }
          ]
        },
        {
          "name": "industry_stakeholders",
          "type": "directory",
          "path": "community/industry_stakeholders",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/industry_stakeholders/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for industry stakeholders including pharmaceutical companies, insurance companies, biotech firms, and medical device manufacturers contributing to the project.",
                "emoji": "üë•",
                "title": "Industry Stakeholders Directory",
                "tags": "fda-community, stakeholders, pharmaceuticals, biotech, medical-devices, insurance, decentralized-fda",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:51:58.855Z",
                "dateCreated": "2025-02-12T16:51:58.855Z"
              }
            }
          ]
        },
        {
          "name": "open-source-projects",
          "type": "directory",
          "path": "community/open-source-projects",
          "children": [
            {
              "name": "open-source-projects.md",
              "type": "file",
              "path": "community/open-source-projects/open-source-projects.md",
              "children": [],
              "metadata": {
                "description": "A list of open-source projects aimed at accelerating clinical discovery relevant to the dFDA's mission.",
                "emoji": "üíª",
                "title": "Open Source Projects for Clinical Discovery",
                "tags": "open-source, clinical-discovery, projects",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:01.808Z",
                "dateCreated": "2025-02-12T16:52:01.808Z"
              }
            }
          ]
        },
        {
          "name": "opencures.md",
          "type": "file",
          "path": "community/opencures.md",
          "children": [],
          "metadata": {
            "description": "OpenCures is a platform that accelerates intervention development by empowering individuals with advanced personal health management tools and connecting them to research through data ownership, biobanking, and trial management services.",
            "emoji": "ü©∏",
            "title": "OpenCures",
            "tags": "health-data, biobanking, clinical-trials, personal-health-management, research",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-26T20:24:32.745Z",
            "dateCreated": "2022-07-27T21:22:28.927Z"
          }
        },
        {
          "name": "partners",
          "type": "directory",
          "path": "community/partners",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/partners/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for partners involved in the project, providing a space for organizations to introduce themselves, share their roles, and facilitate collaboration.",
                "emoji": "ü§ù",
                "title": "Partners Directory",
                "tags": "partners, collaboration, community-directory",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:04.915Z",
                "dateCreated": "2025-02-12T16:52:04.915Z"
              }
            },
            {
              "name": "ageless-partners.md",
              "type": "file",
              "path": "community/partners/ageless-partners.md",
              "children": [],
              "metadata": {
                "description": "Ageless Partners LLC is a research company focused on developing machine learning and AI innovations for analyzing complex datasets to reverse aging and advance anti-aging medical science.",
                "emoji": "evity",
                "title": "ageless-partners",
                "tags": "anti-aging, machine-learning, artificial-intelligence, personalized-medicine, healthcare, research",
                "published": true,
                "editor": "markdown",
                "date": "2022-09-01T10:52:19.940Z",
                "dateCreated": "2022-07-27T21:22:20.859Z"
              }
            }
          ]
        },
        {
          "name": "patient_advocacy",
          "type": "directory",
          "path": "community/patient_advocacy",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/patient_advocacy/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for patient advocacy groups and NGOs to share information, resources, and collaborate within the Community Directory.",
                "emoji": "ü§ù",
                "title": "Patient Advocacy Directory",
                "tags": "patient-advocacy, NGOs, community-directory, collaboration",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:08.134Z",
                "dateCreated": "2025-02-12T16:52:08.134Z"
              }
            },
            {
              "name": "crowdsourcing-cures.md",
              "type": "file",
              "path": "community/patient_advocacy/crowdsourcing-cures.md",
              "children": [],
              "metadata": {
                "description": "Exploration of the societal and financial costs of neurological disorders and mental illnesses, emphasizing the potential benefits of redirecting wasted resources towards solving global issues.",
                "emoji": "üß†",
                "title": "Crowdsourcing Cures",
                "tags": "neurological-disorders, mental-health, societal-costs, resource-allocation",
                "published": true,
                "editor": "markdown",
                "date": "2022-08-26T19:04:23.080Z",
                "dateCreated": "2022-07-27T21:22:24.826Z"
              }
            }
          ]
        },
        {
          "name": "projects",
          "type": "directory",
          "path": "community/projects",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/projects/README.md",
              "children": [],
              "metadata": {
                "description": "A directory of projects within the dFDA initiative, providing descriptions, requirements, and collaboration opportunities.",
                "emoji": "üìö",
                "title": "projects Directory",
                "tags": "dFDA, projects, collaboration, community",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:10.998Z",
                "dateCreated": "2025-02-12T16:52:10.998Z"
              }
            }
          ]
        },
        {
          "name": "regulatory_legal",
          "type": "directory",
          "path": "community/regulatory_legal",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/regulatory_legal/README.md",
              "children": [],
              "metadata": {
                "description": "Directory for regulatory and legal partners involved in healthcare and pharmaceuticals, focusing on sharing insights and collaborating on legal frameworks for decentralized health technologies.",
                "emoji": "üìö",
                "title": "Regulatory and Legal Partners Directory",
                "tags": "regulatory, legal, healthcare, pharmaceuticals, decentralized-health, dFDA",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:17.592Z",
                "dateCreated": "2025-02-12T16:52:17.592Z"
              }
            }
          ]
        },
        {
          "name": "researchers",
          "type": "directory",
          "path": "community/researchers",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/researchers/README.md",
              "children": [],
              "metadata": {
                "description": "A directory for academic and medical researchers contributing to the dFDA project, facilitating collaboration and resource sharing.",
                "emoji": "üìö",
                "title": "Researchers Directory",
                "tags": "researchers, collaboration, resources",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:20.436Z",
                "dateCreated": "2025-02-12T16:52:20.436Z"
              }
            }
          ]
        },
        {
          "name": "resources",
          "type": "directory",
          "path": "community/resources",
          "children": [
            {
              "name": "README.md",
              "type": "file",
              "path": "community/resources/README.md",
              "children": [],
              "metadata": {
                "description": "Central hub for shared resources, guides, tools, documentation, coding standards, and data handling protocols for the project",
                "emoji": "üìö",
                "title": "Resources Directory for dFDA",
                "tags": "dFDA, resources, guides, tools, documentation, coding-standards, data-handling",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:23.865Z",
                "dateCreated": "2025-02-12T16:52:23.865Z"
              }
            }
          ]
        },
        {
          "name": "templates",
          "type": "directory",
          "path": "community/templates",
          "children": [
            {
              "name": "open_source_project.md",
              "type": "file",
              "path": "community/templates/open_source_project.md",
              "children": [],
              "metadata": {
                "description": "An open-source project with details on its repository, license, features, contribution guidelines, donation information, and contact details.",
                "emoji": "üåü",
                "title": "Open-Source Project Overview",
                "tags": "open-source, github, contribution, donation, project-management",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:27.046Z",
                "dateCreated": "2025-02-12T16:52:27.046Z"
              }
            },
            {
              "name": "partner_introduction.md",
              "type": "file",
              "path": "community/templates/partner_introduction.md",
              "children": [],
              "metadata": {
                "description": "A template for partners to introduce themselves in the Community Directory",
                "emoji": "ü§ù",
                "title": "Partner Introduction Template",
                "tags": "community, partners, template, collaboration",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:29.661Z",
                "dateCreated": "2025-02-12T16:52:29.661Z"
              }
            },
            {
              "name": "project_proposal.md",
              "type": "file",
              "path": "community/templates/project_proposal.md",
              "children": [],
              "metadata": {
                "description": "A template for structuring project proposals for the Community Directory, guiding contributors to provide detailed information about their initiatives.",
                "emoji": "üìã",
                "title": "project Proposal Template",
                "tags": "fda-community, project-proposals, template, guidelines",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:32.792Z",
                "dateCreated": "2025-02-12T16:52:32.792Z"
              }
            }
          ]
        },
        {
          "name": "weavechain.md",
          "type": "file",
          "path": "community/weavechain.md",
          "children": [],
          "metadata": {
            "title": "Weavechain",
            "description": "Weavechain seamlessly integrates into your existing setup and gives your data  the power of Web3.",
            "published": true,
            "date": "2023-05-22T22:04:58.375Z",
            "tags": "data sharing, data security, 1st party analytics, data monetization, data lineage",
            "editor": "markdown",
            "dateCreated": "2022-11-18T02:41:12.412Z"
          }
        }
      ]
    },
    {
      "name": "conditions",
      "type": "directory",
      "path": "conditions",
      "children": [
        {
          "name": "scabies.md",
          "type": "file",
          "path": "conditions/scabies.md",
          "children": [],
          "metadata": {
            "title": "Scabies",
            "description": "Scabies is a parasitic skin infestation caused by the mite *Sarcoptes scabiei* that affects millions of people worldwide. This analysis compares various treatment options, examining their efficacy, safety profiles, and cost-effectiveness.",
            "published": true,
            "date": "2025-01-22T08:07:55.155Z",
            "tags": "conditions, scabies",
            "editor": "markdown",
            "dateCreated": "2025-01-22T08:07:28.742Z"
          }
        }
      ]
    },
    {
      "name": "dfda-sitemap.md",
      "type": "file",
      "path": "dfda-sitemap.md",
      "children": [],
      "metadata": {
        "description": "Overview of top-level pages for the dFDA wiki, including Home, About, Get Involved, and Treatments & Rankings sections.",
        "emoji": "üìö",
        "title": "dFDA Top-Level Pages",
        "tags": "dfda, wiki-structure, decentralized-fda, treatments, rankings",
        "published": true,
        "editor": "markdown",
        "date": "2025-02-12T16:53:35.481Z",
        "dateCreated": "2025-02-12T16:53:35.481Z"
      }
    },
    {
      "name": "disease-eradication-act",
      "type": "directory",
      "path": "disease-eradication-act",
      "children": [
        {
          "name": "disease-eradication-act-cost-benefit-analysis.md",
          "type": "file",
          "path": "disease-eradication-act/disease-eradication-act-cost-benefit-analysis.md",
          "children": [],
          "metadata": {
            "description": "Quantitative analysis of the economic impacts of the Disease Eradication Act, estimating up to $2.25 trillion in annual benefits with costs around $10 billion.",
            "emoji": "üìä",
            "title": "Quantitative Cost-Benefit Analysis of the Disease Eradication Act",
            "tags": "disease-eradication-act, cost-benefit-analysis, healthcare-policy, economic-impact",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:39.410Z",
            "dateCreated": "2025-02-12T16:53:39.410Z"
          }
        },
        {
          "name": "disease-eradication-act-details.md",
          "type": "file",
          "path": "disease-eradication-act/disease-eradication-act-details.md",
          "children": [],
          "metadata": {
            "description": "Legislation aiming to reform the FDA approval process by addressing delays, accessibility issues, and high costs in drug development.",
            "emoji": "üè•",
            "title": "Disease Eradication Act",
            "tags": "FDA-reform, drug-development, clinical-trials, health-policy, legislation",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:42.927Z",
            "dateCreated": "2025-02-12T16:53:42.927Z"
          }
        },
        {
          "name": "disease-eradication-act-summary.md",
          "type": "file",
          "path": "disease-eradication-act/disease-eradication-act-summary.md",
          "children": [],
          "metadata": {
            "description": "Executive summary of the Disease Eradication Act, focusing on patient rights, decentralized trials, and reducing costs in drug development.",
            "emoji": "üíñ",
            "title": "Disease Eradication Act: Executive Summary",
            "tags": "decentralized-trials, patient-rights, drug-development, cost-reduction, FDA-reform",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:46.416Z",
            "dateCreated": "2025-02-12T16:53:46.416Z"
          }
        },
        {
          "name": "disease-eradication-act.md",
          "type": "file",
          "path": "act.md",
          "children": [],
          "metadata": {
            "description": "The Disease Eradication Act aims to address systemic issues in healthcare, including bureaucratic delays, high drug development costs, limited clinical trial access, and focus on expensive treatments.",
            "emoji": "üíñ",
            "title": "Disease Eradication Act",
            "tags": "healthcare-reform, clinical-trials, drug-development, policy, regulatory",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:56:04.572Z",
            "dateCreated": "2025-02-12T16:56:04.572Z"
          }
        }
      ]
    },
    {
      "name": "economic-models",
      "type": "directory",
      "path": "economic-models",
      "children": [
        {
          "name": "benfits-of-over-the-counter-classification.md",
          "type": "file",
          "path": "economic-models/benfits-of-over-the-counter-classification.md",
          "children": [],
          "metadata": {
            "title": "Economic Impact of Prescription-Only Classification for Safe Drugs",
            "description": "Many safe medications remain prescription-only, imposing unnecessary costs and barriers on patients despite potential savings of $146 billion annually through over-the-counter alternatives.",
            "published": true,
            "date": "2025-02-27T07:36:31.836Z",
            "tags": "healthcare-policy, prescription-drugs, over-the-counter, economic-impact, healthcare-costs",
            "editor": "markdown",
            "dateCreated": "2025-02-27T07:36:31.836Z"
          }
        },
        {
          "name": "cost-benefit-analysis-for-drug-classification.md",
          "type": "file",
          "path": "economic-models/cost-benefit-analysis-for-drug-classification.md",
          "children": [],
          "metadata": {
            "description": "Analysis of how prescription-to-OTC switches impact drug prices and accessibility, with examples like Zyrtec showing significant price reductions.",
            "emoji": "üíä",
            "title": "Rx-to-OTC Switch Impact on Drug Prices and Access",
            "tags": "drug-prices, otc-switch, accessibility, pharmaceuticals",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:40.191Z",
            "dateCreated": "2025-02-12T20:29:40.191Z"
          }
        },
        {
          "name": "dfda-cost-benefit-analysis.md",
          "type": "file",
          "path": "economic-models/dfda-cost-benefit-analysis.md",
          "children": [],
          "metadata": {
            "title": "dFDA Cost Benefit Analysis and Return on Inveestment",
            "description": "The analysis indicates that a global, decentralized FDA platform could slash per-patient trial costs by up to 80√ó and generate roughly $45 billion in net annual savings, resulting in an ROI of approximately 9:1.",
            "published": true,
            "date": "2025-02-09T16:58:25.534Z",
            "tags": "economic-models",
            "editor": "markdown",
            "dateCreated": "2025-02-02T07:33:37.361Z"
          }
        },
        {
          "name": "nih-grant-efficiency-analysis.md",
          "type": "file",
          "path": "economic-models/nih-grant-efficiency-analysis.md",
          "children": [],
          "metadata": {
            "title": "NIH Grant Process Efficiency Analysis",
            "description": "Analysis reveals significant inefficiencies in NIH funding allocation and proposes an 83x more efficient system with a 98.8% cost reduction per trial participant.",
            "published": true,
            "date": "2025-02-20T05:43:17.021Z",
            "tags": "NIH, grant-process, efficiency-analysis, clinical-trials, biomedical-research",
            "editor": "markdown",
            "dateCreated": "2025-02-20T05:43:17.021Z"
          }
        },
        {
          "name": "quantitative-value-medical-treatment.md",
          "type": "file",
          "path": "economic-models/quantitative-value-medical-treatment.md",
          "children": [],
          "metadata": {
            "title": "Quantifying the Value of Medical Treatments to Humanity",
            "description": "Evaluating medical treatments using Quality-Adjusted Life Years (QALYs) to measure both quantity and quality of life improvements.",
            "published": true,
            "date": "2025-02-20T05:43:21.814Z",
            "tags": "medical-treatments, QALYs, healthcare-economics, quantitative-analysis",
            "editor": "markdown",
            "dateCreated": "2025-02-20T05:43:21.814Z"
          }
        }
      ]
    },
    {
      "name": "economic-models.md",
      "type": "file",
      "path": "economic-models.md",
      "children": [],
      "metadata": {
        "description": "Various analyses illustrating the benefits of a global system for automating decentralized clinical trials",
        "emoji": "üìä",
        "title": "Economic Models and Cost-Benefit Analyses of Decentralized FDA",
        "tags": "economic-models, cost-benefit-analysis, decentralized-clinical-trials, FDA",
        "published": true,
        "editor": "markdown",
        "date": "2025-02-12T16:54:02.221Z",
        "dateCreated": "2025-02-12T16:54:02.221Z"
      }
    },
    {
      "name": "features",
      "type": "directory",
      "path": "features",
      "children": [
        {
          "name": "analytics",
          "type": "directory",
          "path": "features/analytics",
          "children": [
            {
              "name": "causal-inference-analysis.md",
              "type": "file",
              "path": "features/analytics/causal-inference-analysis.md",
              "children": [],
              "metadata": {
                "title": "Causal Inference Analysis",
                "description": "A comprehensive guide to robust statistical analysis of treatment effects from challenging sparse, irregular time series data with missing values.",
                "published": true,
                "date": "2023-10-02T04:41:41.031Z",
                "tags": "causal inference, data analysis, treatment effects, time series",
                "editor": "markdown",
                "dateCreated": "2023-10-02T04:38:36.182Z"
              }
            }
          ]
        },
        {
          "name": "browser-extension",
          "type": "directory",
          "path": "features/browser-extension",
          "children": [
            {
              "name": "browser-extension.md",
              "type": "file",
              "path": "features/browser-extension/browser-extension.md",
              "children": [],
              "metadata": {
                "description": "A browser extension that allows users to track their mood, symptoms, or desired outcomes quickly through a popup interface.",
                "emoji": "üíª",
                "title": "Browser Extension for Tracking Outcomes",
                "tags": "browser-extension, tracking, mood, symptoms, open-source, development",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:36.010Z",
                "dateCreated": "2025-02-12T16:52:36.010Z"
              }
            }
          ]
        },
        {
          "name": "clinipedia",
          "type": "directory",
          "path": "features/clinipedia",
          "children": [
            {
              "name": "clinipedia.md",
              "type": "file",
              "path": "features/clinipedia/clinipedia.md",
              "children": [],
              "metadata": {
                "description": "A comprehensive wiki aggregating all data on the effects of foods, drugs, supplements, and medical interventions on human health",
                "emoji": "üìö",
                "title": "Clinipedia: The Wikipedia of Clinical Research",
                "tags": "clinical-research, data-aggregation, knowledge-base, ai-research, health-outcomes",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:52:39.500Z",
                "dateCreated": "2025-02-12T16:52:39.500Z"
              }
            }
          ]
        },
        {
          "name": "data-analysis.md",
          "type": "file",
          "path": "features/data-analysis.md",
          "children": [],
          "metadata": {
            "description": "How to quantify treatment effects from challenging sparse, irregular time series data with missing values.",
            "emoji": "üìà",
            "title": "Causal Inference and Optimal Daily Value Determination",
            "tags": "causal inference, data analysis, treatment effects, time series",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:52:43.098Z",
            "dateCreated": "2025-02-12T16:52:43.098Z"
          }
        },
        {
          "name": "data-collection-plugins.md",
          "type": "file",
          "path": "features/data-collection-plugins.md",
          "children": [],
          "metadata": {
            "description": "Data collection can be done using wearable sensors, third-party applications, and client applications.",
            "emoji": "üìä",
            "title": "üì≤ Data Collection Plugins",
            "tags": "data-collection, clinical-research, omics-data, imaging-data, wearable-sensors",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-28T15:16:12.088Z",
            "dateCreated": "2022-07-27T21:22:48.973Z"
          }
        },
        {
          "name": "data-collection.md",
          "type": "file",
          "path": "features/data-collection.md",
          "children": [],
          "metadata": {
            "description": "Overview of data collection methods and data types including wearable sensors, third-party applications, and various data categories such as omics, clinical, and multiscale data.",
            "emoji": "üì≤",
            "title": "Data Collection Methods and Types",
            "tags": "data-collection, wearable-sensors, omics-data, clinical-data, multiscale-data",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:52:46.729Z",
            "dateCreated": "2025-02-12T16:52:46.729Z"
          }
        },
        {
          "name": "data-import.md",
          "type": "file",
          "path": "features/data-import.md",
          "children": [],
          "metadata": {
            "description": "Framework for importing and normalizing data from various health and productivity applications and devices",
            "emoji": "üï∏",
            "title": "Data Import Framework",
            "tags": "data-import, connectors, health-data, productivity, normalization",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:52:52.985Z",
            "dateCreated": "2025-02-12T16:52:52.985Z"
          }
        },
        {
          "name": "data-silo-api-gateways.md",
          "type": "file",
          "path": "features/data-silo-api-gateways.md",
          "children": [],
          "metadata": {
            "description": "FDAi Gateway API Nodes enable data silos to allow individuals to export and save their data locally in PersonalFDA Nodes with secure OAuth2-protected APIs and personal access token management.",
            "emoji": "‚öôÔ∏è",
            "title": "FDAi Gateway API Nodes",
            "tags": "data-silo, api-gateway, fda, personal-data, oauth2, access-tokens",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:52:56.730Z",
            "dateCreated": "2025-02-12T16:52:56.730Z"
          }
        },
        {
          "name": "decision-support-notifications.md",
          "type": "file",
          "path": "features/decision-support-notifications.md",
          "children": [],
          "metadata": {
            "title": "Decision Support Notifications",
            "description": "Get notifications telling you the most important thing (MIT) you can do at any given time to optimize your health and happiness.",
            "cover": "notifications-screenshot-slide.png",
            "coverY": 203.93538913362704
          }
        },
        {
          "name": "desci-exchange.md",
          "type": "file",
          "path": "features/desci-exchange.md",
          "children": [],
          "metadata": {
            "title": "DeSci Exchange",
            "description": "A Free Market for Accelerating Scientific Discovery",
            "published": true,
            "date": "2022-11-05T02:54:03.172Z",
            "tags": "projects, github",
            "editor": "markdown",
            "dateCreated": "2022-11-05T02:49:24.504Z"
          }
        },
        {
          "name": "digital-twin-safe.md",
          "type": "file",
          "path": "features/digital-twin-safe.md",
          "children": [],
          "metadata": {
            "title": "üë®‚Äçü§ù‚Äçüë® The Digital Twin Safe üîí",
            "description": "A little house for your digital twin. üè°",
            "published": true,
            "date": "2023-06-08T19:52:34.654Z",
            "tags": "projects, data sharing, data storage",
            "editor": "markdown",
            "dateCreated": "2022-11-07T20:38:39.252Z"
          }
        },
        {
          "name": "digital-twin-skeleton-key-nft.md",
          "type": "file",
          "path": "features/digital-twin-skeleton-key-nft.md",
          "children": [],
          "metadata": {
            "title": "Digital Twin Skeleton Key NFT",
            "description": "Data sets can be encrypted and stored in a decentralized manner generating a Data Gem NFT that can be sold on data exchanges granting the possessor access to the data set.",
            "published": true,
            "date": "2023-10-27T18:25:24.971Z",
            "tags": "nft, digital twin safe, data access controls",
            "editor": "markdown",
            "dateCreated": "2023-10-27T18:21:13.091Z"
          }
        },
        {
          "name": "fdai",
          "type": "directory",
          "path": "features/fdai",
          "children": [
            {
              "name": "drug-classification.md",
              "type": "file",
              "path": "features/fdai/drug-classification.md",
              "children": [],
              "metadata": {
                "description": "An overview of the quantitative data and formulas used by regulators to categorize drugs as OTC, prescription-only, or scheduled.",
                "emoji": "üìä",
                "title": "Quantitative Data for Drug Regulation",
                "tags": "drug-regulation, efficacy, safety, quantitative-data",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:34:33.103Z",
                "dateCreated": "2025-02-09T16:34:33.103Z"
              }
            },
            {
              "name": "fdai-act.md",
              "type": "file",
              "path": "features/fdai/fdai-act.md",
              "children": [],
              "metadata": {
                "description": "An Act to revolutionize healthcare through AI and data analysis, focusing on personalized health optimization, accelerated clinical discovery, and global health equity.",
                "emoji": "üè•",
                "title": "The FDA Innovation through Data and AI Act (FDAi Act)",
                "tags": "healthcare, AI, data-analysis, regulation, clinical-research",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:34:38.071Z",
                "dateCreated": "2025-02-09T16:34:38.071Z"
              }
            },
            {
              "name": "fdai-system-prompt.md",
              "type": "file",
              "path": "features/fdai/fdai-system-prompt.md",
              "children": [],
              "metadata": {
                "description": "An autonomous FDAi agent's role in collecting symptom data, analyzing food and drug effects, optimizing diet and supplements, and exploring clinical trials.",
                "emoji": "ü§ñ",
                "title": "Autonomous FDAi Agent for Health Optimization",
                "tags": "health-tech, data-collection, clinical-trials, nutrition, symptom-analysis",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:34:42.986Z",
                "dateCreated": "2025-02-09T16:34:42.986Z"
              }
            },
            {
              "name": "fdai.md",
              "type": "file",
              "path": "features/fdai/fdai.md",
              "children": [],
              "metadata": {
                "description": "Exploration of automating clinical research and its potential cost savings with automated data collection methods.",
                "emoji": "ü§ñ",
                "title": "Automating Clinical Research: Cost Savings and Data Collection",
                "tags": "automation, clinical-research, data-collection, artificial-intelligence",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:34:48.009Z",
                "dateCreated": "2025-02-09T16:34:48.009Z",
                "featuredImage": "black-box-model-animation2.gif"
              }
            },
            {
              "name": "petition.md",
              "type": "file",
              "path": "features/fdai/petition.md",
              "children": [],
              "metadata": {
                "description": "A petition advocating for the creation of the FDAi system to revolutionize healthcare using AI.",
                "emoji": "üè•",
                "title": "Petition for the Establishment of the FDAi System",
                "tags": "healthcare, artificial-intelligence, regulation, policy",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:34:52.601Z",
                "dateCreated": "2025-02-09T16:34:52.601Z"
              }
            },
            {
              "name": "presentation.md",
              "type": "file",
              "path": "features/fdai/presentation.md",
              "children": [],
              "metadata": {
                "description": "Exploration of the potential benefits of personal FDAi agents in addressing health issues caused by untested chemicals and poor diets.",
                "emoji": "üî¨",
                "title": "The Case for Personal FDAi Agents",
                "tags": "health, chronic-diseases, chemicals, microbiome, clinical-trials",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:34:58.059Z",
                "dateCreated": "2025-02-09T16:34:58.059Z",
                "number": "1m",
                "textFollowingNumber": "people commit suicide every year"
              }
            },
            {
              "name": "scenario.md",
              "type": "file",
              "path": "features/fdai/scenario.md",
              "children": [],
              "metadata": {
                "description": "Analysis of inflammation-mediated depression and related symptoms, with dietary adjustment recommendations for a vegetarian patient.",
                "emoji": "üå±",
                "title": "Inflammation-Mediated Depression and Dietary Adjustments",
                "tags": "inflammation, depression, dietary-adjustments, vegetarian, health",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:35:03.599Z",
                "dateCreated": "2025-02-09T16:35:03.599Z",
                "number": "10",
                "textFollowingNumber": "days after exposure to gluten, alcohol, or lectins"
              }
            },
            {
              "name": "simulated-conversation.md",
              "type": "file",
              "path": "features/fdai/simulated-conversation.md",
              "children": [],
              "metadata": {
                "description": "Discussion between a patient and the FDAi agent about health concerns linked to dietary factors.",
                "emoji": "ü©∫",
                "title": "FDAi Agent Analyzes Patient's Health Concerns",
                "tags": "health, diet, inflammation, arthritis, psoriasis, depression",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-09T16:35:09.090Z",
                "dateCreated": "2025-02-09T16:35:09.090Z",
                "number": "10",
                "textFollowingNumber": "days symptoms last after dietary exposure"
              }
            }
          ]
        },
        {
          "name": "global-health-unifier-agent.md",
          "type": "file",
          "path": "features/global-health-unifier-agent.md",
          "children": [],
          "metadata": {
            "description": "A global health agent that accelerates medical progress through the Disease Eradication Act by coordinating decentralized clinical trials and automating research validation.",
            "emoji": "üåç",
            "title": "Global Health Unifier Agent",
            "tags": "global-health, clinical-trials, research-automation, decentralized-research, medical-progress",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-11T14:20:26.909Z",
            "dateCreated": "2025-02-11T14:20:26.909Z"
          }
        },
        {
          "name": "human-file-system-protocol.md",
          "type": "file",
          "path": "features/human-file-system-protocol.md",
          "children": [],
          "metadata": {
            "description": "The Human File System Protocol SDK is a suite of interoperable software libraries, meticulously designed to facilitate the creation of user-access controlled digital twins on the blockchain.",
            "emoji": "üîí",
            "title": "Human File System",
            "tags": "data-aggregation, data sharing, data storage",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:09.454Z",
            "dateCreated": "2025-02-12T16:53:09.454Z"
          }
        },
        {
          "name": "life-force-score-nft.md",
          "type": "file",
          "path": "features/life-force-score-nft.md",
          "children": [],
          "metadata": {
            "description": "Gamification to Incentivize Healthy Behaviour",
            "emoji": "üéÆ",
            "title": "Life Force Score",
            "tags": "digital-twins, nft, metaverse, health-data, gaming",
            "published": true,
            "editor": "markdown",
            "date": "2023-10-26T21:36:53.402Z",
            "dateCreated": "2023-10-26T21:36:53.402Z"
          }
        },
        {
          "name": "no-code-app-builder.md",
          "type": "file",
          "path": "features/no-code-app-builder.md",
          "children": [],
          "metadata": {
            "description": "A platform for creating health data collection and analysis applications without coding skills.",
            "emoji": "üìä",
            "title": "No-Code Health App Builder",
            "tags": "health-data, no-code, app-builder, data-management",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:12.342Z",
            "dateCreated": "2025-02-12T16:53:12.342Z"
          }
        },
        {
          "name": "notifications.md",
          "type": "file",
          "path": "features/notifications.md",
          "children": [],
          "metadata": {
            "description": "Web and mobile push notifications with action buttons for recording treatments and symptoms without opening the app, available on Android, iOS, and desktop browsers.",
            "emoji": "üì±",
            "title": "Notifications with Action Buttons",
            "tags": "notifications, action-buttons, data-collection, mobile, web",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:52:50.084Z",
            "dateCreated": "2025-02-12T16:52:50.084Z"
          }
        },
        {
          "name": "observational-studies.md",
          "type": "file",
          "path": "features/observational-studies.md",
          "children": [],
          "metadata": {
            "description": "A plugin for conducting observational studies, which are used to collect data and identify relationships between variables without intervention.",
            "emoji": "üìë",
            "title": "Observational Studies Plugin",
            "tags": "observational-studies, research-methods, data-collection, scientific-studies",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:15.392Z",
            "dateCreated": "2025-02-12T16:53:15.392Z"
          }
        },
        {
          "name": "optomitron-ai-agent.md",
          "type": "file",
          "path": "features/optomitron-ai-agent.md",
          "children": [],
          "metadata": {
            "description": "Optimitron is an AI agent within PersonalFDA nodes that uses causal inference to analyze health factors and provide personalized recommendations.",
            "emoji": "ü§ñ",
            "title": "Optimitron AI Agent",
            "tags": "ai-agent, causal-inference, personalized-health, data-analysis, pharmacokinetics",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:18.950Z",
            "dateCreated": "2025-02-12T16:53:18.950Z"
          }
        },
        {
          "name": "outcome-labels-plugin.md",
          "type": "file",
          "path": "features/outcome-labels-plugin.md",
          "children": [],
          "metadata": {
            "description": "Proposal for replacing traditional nutrition labels with outcome labels to better inform consumers about health impacts",
            "emoji": "üìä",
            "title": "üè∑ Outcome Labels Plugin",
            "tags": "nutrition, health-outcomes, food-labels, public-health",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-28T15:12:30.345Z",
            "dateCreated": "2022-07-27T21:23:05.142Z"
          }
        },
        {
          "name": "outcome-labels.md",
          "type": "file",
          "path": "features/outcome-labels.md",
          "children": [],
          "metadata": {
            "description": "Introduction to Outcome Labels, a new approach to food and product labeling focusing on health outcomes and symptoms rather than micronutrients.",
            "emoji": "üè∑",
            "title": "Outcome Labels",
            "tags": "health, nutrition, food-labels, chronic-disease, innovation",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:22.107Z",
            "dateCreated": "2025-02-12T16:53:22.107Z"
          }
        },
        {
          "name": "personal-fda-nodes.md",
          "type": "file",
          "path": "features/personal-fda-nodes.md",
          "children": [],
          "metadata": {
            "description": "PersonalFDA Nodes are applications that run on personal devices to store and analyze health data using a Digital Twin Safe and an AI agent called Optimitron.",
            "emoji": "ü§ñ",
            "title": "PersonalFDA Nodes",
            "tags": "personal-health, data-analysis, AI-agent, Digital-Twin-Safe, Optimitron",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:25.518Z",
            "dateCreated": "2025-02-12T16:53:25.518Z"
          }
        },
        {
          "name": "predictor-search-engine.md",
          "type": "file",
          "path": "features/predictor-search-engine.md",
          "children": [],
          "metadata": {
            "description": "A search engine plugin that uses aggregated user data to identify factors influencing health, offering personalized effectiveness rates of treatments.",
            "emoji": "üîç",
            "title": "Predictor Search Engine Plugin",
            "tags": "health, wellness, search-engine, personalized-medicine, data-aggregation",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:28.700Z",
            "dateCreated": "2025-02-12T16:53:28.700Z"
          }
        },
        {
          "name": "root-cause-analysis-plugin.md",
          "type": "file",
          "path": "features/root-cause-analysis-plugin.md",
          "children": [],
          "metadata": {
            "description": "Reports are intended to help you and your physician to gain insight into the root causes and effective solutions to help you minimize your symptoms.",
            "emoji": " Ëá™Âä®ÁîüÊàêÁöÑÊä•Âëä üìä",
            "title": "ü•ï Root Cause Analysis Plugin",
            "tags": "root-cause-analysis, health, symptoms, CuroBot",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-28T15:10:37.898Z",
            "dateCreated": "2022-07-27T21:23:13.115Z"
          }
        },
        {
          "name": "root-cause-analysis-reports.md",
          "type": "file",
          "path": "features/root-cause-analysis-reports.md",
          "children": [],
          "metadata": {
            "description": "Analysis of the failures in current clinical research systems leading to high costs and lack of data on non-patentable factors affecting chronic conditions",
            "emoji": "üîç",
            "title": "Root Cause Analysis Reports",
            "tags": "clinical-research, autoimmune-diseases, mental-health, costs, data-gaps",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:53:32.075Z",
            "dateCreated": "2025-02-12T16:53:32.075Z"
          }
        },
        {
          "name": "study-review-agent.md",
          "type": "file",
          "path": "features/study-review-agent.md",
          "children": [],
          "metadata": {
            "description": "A review agent responsible for analyzing study plausibility, validating data quality, and conducting temporality analysis in research studies.",
            "emoji": "üîç",
            "title": "Study Review Agent",
            "tags": "study-review, data-validation, plausibility, temporality-analysis, research-methodology",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-11T14:23:44.900Z",
            "dateCreated": "2025-02-11T14:23:44.900Z"
          }
        }
      ]
    },
    {
      "name": "home.md",
      "type": "file",
      "path": "home.md",
      "children": [],
      "metadata": {
        "title": "üí° The Decentralized FDA",
        "description": "80Xing medical progress by giving all patients the right to effortlessly participate in global decentralized clinical trials üíä",
        "published": true,
        "date": "2025-03-06T22:55:07.316Z",
        "tags": "overview",
        "editor": "markdown",
        "dateCreated": "2023-11-24T22:24:09.275Z"
      }
    },
    {
      "name": "interventions",
      "type": "directory",
      "path": "interventions",
      "children": [
        {
          "name": "cerebrolysin.md",
          "type": "file",
          "path": "interventions/cerebrolysin.md",
          "children": [],
          "metadata": {
            "title": "Cerebrolysin",
            "description": "A neuropeptide preparation used for neurological conditions. Learn about its potential benefits for stroke, dementia, and traumatic brain injury recovery.",
            "published": true,
            "date": "2024-07-28T01:27:38.634Z",
            "tags": "interventions, cognitive function",
            "editor": "markdown",
            "dateCreated": "2024-07-28T01:27:38.634Z"
          }
        },
        {
          "name": "focused-ultrasound.md",
          "type": "file",
          "path": "interventions/focused-ultrasound.md",
          "children": [],
          "metadata": {
            "description": "Summary of completed studies on the use of focused ultrasound for treating depression, including findings on safety and efficacy.",
            "emoji": "üß†",
            "title": "Focused Ultrasound",
            "tags": "focused-ultrasound, depression, MDD, OCD, treatment-resistant, clinical-studies",
            "published": true,
            "editor": "markdown",
            "date": "2023-10-02T01:47:34.315Z",
            "dateCreated": "2023-10-02T01:37:27.297Z"
          }
        },
        {
          "name": "memantine.md",
          "type": "file",
          "path": "interventions/memantine.md",
          "children": [],
          "metadata": {
            "title": "Memantine",
            "description": "Memantine is a medication used to treat moderate to severe Alzheimer's disease. This article discusses its mechanism of action, effectiveness in treating various conditions, and comparisons to alternative treatments.",
            "published": true,
            "date": "2023-05-03T05:19:05.308Z",
            "tags": "interventions, nmda antagonists, depression, treatments, alzheimer's disease, nmda receptor antagonist, neurological disorders, glutamate, cognitive function, dementia, namenda, excitotoxicity, neuroprotection",
            "editor": "markdown",
            "dateCreated": "2023-05-02T20:02:05.144Z"
          }
        }
      ]
    },
    {
      "name": "logical-proof-to-focus-on-dfda.md",
      "type": "file",
      "path": "logical-proof-to-focus-on-dfda.md",
      "children": [],
      "metadata": {
        "title": "A Logical Proof That We Should Immediately Create A Decentralized FDA",
        "description": "Why we should drop everything and decentralize the FDA first",
        "published": true,
        "date": "2024-12-22T20:52:45.977Z",
        "tags": "dfda, logical-proof",
        "editor": "markdown",
        "dateCreated": "2024-12-22T20:52:45.977Z"
      }
    },
    {
      "name": "one-pager.md",
      "type": "file",
      "path": "one-pager.md",
      "children": [],
      "metadata": {
        "description": "A proposal for a decentralized autonomous FDA (dFDA) aiming to reduce clinical trial costs, provide personalized treatment recommendations, and ensure comprehensive transparency in drug evaluation.",
        "emoji": "üåê",
        "title": "Decentralized Autonomous FDA (dFDA) Proposal",
        "tags": "decentralized-fda, clinical-research, cost-reduction, personalized-medicine, transparency",
        "published": true,
        "editor": "markdown",
        "date": "2025-02-12T16:55:11.895Z",
        "dateCreated": "2025-02-12T16:55:11.895Z"
      }
    },
    {
      "name": "problems",
      "type": "directory",
      "path": "problems",
      "children": [
        {
          "name": "bias-against-approval.md",
          "type": "file",
          "path": "problems/bias-against-approval.md",
          "children": [],
          "metadata": {
            "description": "Overcoming Cognitive Bias Against Acts of Commission",
            "emoji": "üß†",
            "title": "üßÆ Bias Against Approving Effective Treatments",
            "tags": "cognitive-bias, FDA, regulation, decision-making",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-28T03:57:38.074Z",
            "dateCreated": "2022-07-22T19:03:21.545Z"
          }
        },
        {
          "name": "clinical-research-is-expensive.md",
          "type": "file",
          "path": "problems/clinical-research-is-expensive.md",
          "children": [],
          "metadata": {
            "title": "Clinical Research is Expensive",
            "description": "It costs $1.6 billion to bring a drug to market (including failed attempts) and trials currently cost over $36k per participant.",
            "emoji": "üí∞",
            "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/cost-of-clinical-trials.png"
          }
        },
        {
          "name": "clinical-research-is-slow.md",
          "type": "file",
          "path": "problems/clinical-research-is-slow.md",
          "children": [],
          "metadata": {
            "title": "Clinical Research is Slow",
            "description": "It takes an average of 17 years for new treatments to reach patients.",
            "emoji": "‚åõ"
          }
        },
        {
          "name": "clinical-research-is-too-expensive.md",
          "type": "file",
          "path": "problems/clinical-research-is-too-expensive.md",
          "children": [],
          "metadata": {
            "description": "It costs $2.6 billion to bring a drug to market (including failed attempts).",
            "emoji": "üí∞",
            "title": "üí∞ Clinical Research is Too Expensive",
            "tags": "clinical-research, costs, drug-development, phase-iii-trials",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-28T03:58:50.155Z",
            "dateCreated": "2022-07-22T19:03:26.235Z"
          }
        },
        {
          "name": "conflicts-of-interest.md",
          "type": "file",
          "path": "problems/conflicts-of-interest.md",
          "children": [],
          "metadata": {
            "description": "When billions of dollars in losses or gains are riding on the results of a study, this will almost inevitably influence the results.",
            "emoji": "üìä",
            "title": "üé≠ Conflicts of Interest Industry-Controlled Research",
            "tags": "clinical-trials, conflict-of-interest, pharmaceuticals, beverage-studies",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-29T01:56:32.735Z",
            "dateCreated": "2022-07-22T19:03:31.052Z"
          }
        },
        {
          "name": "deaths-due-to-us-regulatory-drug-lag.md",
          "type": "file",
          "path": "problems/deaths-due-to-us-regulatory-drug-lag.md",
          "children": [],
          "metadata": {
            "title": "Deaths Due to US Regulatory Drug Lag",
            "description": "Delays in new interventions cost anywhere from 21,000 to 120,000 US lives per decade.",
            "emoji": "‚è±",
            "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/us-swiss-life-expectancy-drug-approvals.png"
          }
        },
        {
          "name": "difficulty-participating.md",
          "type": "file",
          "path": "problems/difficulty-participating.md",
          "children": [],
          "metadata": {
            "title": "90% of Willing Patients Do Not Participate in Clinical Trials",
            "description": "A significant gap exists between the number of patients willing to participate in clinical trials and those who actually do. Studies indicate that while 68% of patients express interest in participating, only 9% report being invited to a clinical trial.",
            "emoji": "üöß"
          }
        },
        {
          "name": "drug-lag.md",
          "type": "file",
          "path": "problems/drug-lag.md",
          "children": [],
          "metadata": {
            "description": "A comparative analysis between countries suggests that delays in new interventions cost anywhere from 21,000 to 120, 000 US lives per decade.",
            "emoji": "üíÄ",
            "title": "‚è± Deaths Due to US Regulatory \"Drug Lag\"",
            "tags": "regulatory-delay, drug-lag, life-expectancy, FDA, Switzerland-US-comparison",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-29T02:11:03.058Z",
            "dateCreated": "2022-07-22T19:03:35.580Z"
          }
        },
        {
          "name": "fda-decisions-not-based-on-cost-benefit-analysis.md",
          "type": "file",
          "path": "problems/fda-decisions-not-based-on-cost-benefit-analysis.md",
          "children": [],
          "metadata": {
            "title": "Lack of Logical Reasoning Based on Quantitative Cost-Benefit Analysis in FDA Decisions",
            "description": "FDA regulatory decisions often lack logical reasoning based on quantitative cost-benefit analysis.",
            "emoji": "ü§™"
          }
        },
        {
          "name": "insufficient-roi-to-discover-treatments-for-rare-diseases.md",
          "type": "file",
          "path": "problems/insufficient-roi-to-discover-treatments-for-rare-diseases.md",
          "children": [],
          "metadata": {
            "description": "In the case of rare diseases, increasing the cost of treatment development to over a billion makes it impossible to recover your investment from a small number of patients.",
            "emoji": "üî¨",
            "title": "ü§í Insufficient ROI to Discover Treatments for Rare Diseases",
            "tags": "rare-diseases, self-experimentation, regulatory-burdens, harm-reduction, data-collection",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-18T07:59:09.359Z",
            "dateCreated": "2022-07-22T19:03:45.469Z"
          }
        },
        {
          "name": "monopolies.md",
          "type": "file",
          "path": "problems/monopolies.md",
          "children": [],
          "metadata": {
            "description": "The 1962 efficacy amendment made drugs more expensive by granting longer monopolies.",
            "emoji": "ü§ñ",
            "title": "üé© Excessive Patent Monopolies",
            "tags": "content, tokens, efficiency",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-29T01:55:49.553Z",
            "dateCreated": "2022-07-22T19:03:40.532Z"
          }
        },
        {
          "name": "negative-results-are-never-published.md",
          "type": "file",
          "path": "problems/negative-results-are-never-published.md",
          "children": [],
          "metadata": {
            "title": "Negative Results are Never Published",
            "description": "We waste billions of dollars repeating failed drug trials because companies only publish the positive results.",
            "emoji": "üôà"
          }
        },
        {
          "name": "no-comparative-effectiveness-rankings.md",
          "type": "file",
          "path": "problems/no-comparative-effectiveness-rankings.md",
          "children": [],
          "metadata": {
            "title": "No Treatment Effectiveness Rankings",
            "description": "Shockingly, the existing system does not give us a ranked list of the most safe and effective treatments for a given condition.",
            "emoji": "üìä"
          }
        },
        {
          "name": "no-data-on-unpatentable-molecules.md",
          "type": "file",
          "path": "problems/no-data-on-unpatentable-molecules.md",
          "children": [],
          "metadata": {
            "title": "No Data on Unpatentable Treatments",
            "description": "We still know next to nothing about the long-term effects of 99.9% of the 4 pounds of over 7,000 different synthetic or natural chemicals you consume every day.",
            "emoji": "ü•´",
            "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/how-much-we-know (1) (1) (1).png"
          }
        },
        {
          "name": "no-incentive-to-discover-benefits-of-off-patent-treatments.md",
          "type": "file",
          "path": "problems/no-incentive-to-discover-benefits-of-off-patent-treatments.md",
          "children": [],
          "metadata": {
            "description": "If a drug is found to be effective for other diseases after the patent has expired, no one has the financial incentive to get it approved for another disease.",
            "emoji": "ü©∫",
            "title": "üìÉ No Incentive to Discover Benefits of Off-Patent Treatments",
            "tags": "orphan-diseases, drug-approval, pharmaceuticals, clinical-trials",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-18T08:00:43.662Z",
            "dateCreated": "2022-07-22T19:03:58.465Z"
          }
        },
        {
          "name": "no-long-term-outcome-data.md",
          "type": "file",
          "path": "problems/no-long-term-outcome-data.md",
          "children": [],
          "metadata": {
            "title": "No Long-Term Outcome Data",
            "description": "Current trials often only last a few months, so we have no idea what the long-term positive or negative effects of a drug are!",
            "emoji": "üóì"
          }
        },
        {
          "name": "people-with-rare-disease-are-severely-punished.md",
          "type": "file",
          "path": "problems/people-with-rare-disease-are-severely-punished.md",
          "children": [],
          "metadata": {
            "title": "People With Rare Disease are Severely Punished",
            "description": "It's impossible to recover a billion dollars of drug development from a small number of patients.",
            "emoji": "ü§í"
          }
        },
        {
          "name": "pre-determining-clinical-endpoints-requires-psychic-powers.md",
          "type": "file",
          "path": "problems/pre-determining-clinical-endpoints-requires-psychic-powers.md",
          "children": [],
          "metadata": {
            "title": "Pre-Determining Clinical Endpoints Requires Psychic Powers",
            "description": "Drug Developers to Have Psychic Powers Needed to Pre-Determine Very Specific Clinical Endpoints Before Collecting Data",
            "emoji": "üîÆ"
          }
        },
        {
          "name": "problems-in-clinical-research.md",
          "type": "file",
          "path": "problems/problems-in-clinical-research.md",
          "children": [],
          "metadata": {
            "title": "Problems in Clinical Research",
            "description": "The existing regulatory framework for drug approval presents several challenges, hindering the efficiency and effectiveness of pharmaceutical research and public health.",
            "published": true,
            "date": "2023-10-26T19:50:44.089Z",
            "tags": "dfda, fda, problems, clinical research",
            "editor": "markdown",
            "dateCreated": "2023-10-26T19:50:44.089Z"
          }
        },
        {
          "name": "slowed-growth-in-life-expectancy.md",
          "type": "file",
          "path": "problems/slowed-growth-in-life-expectancy.md",
          "children": [],
          "metadata": {
            "description": "Following this new 70% reduction in the pace of medical progress, the growth in human lifespan was immediately cut in half to an increase of 2 years per decade.",
            "emoji": "üìà",
            "title": "‚ò† Slowed Growth in Life Expectancy",
            "tags": "life-expectancy, medical-progress, diminishing-returns, regulations",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-31T17:06:24.891Z",
            "dateCreated": "2022-07-22T19:04:12.318Z"
          }
        },
        {
          "name": "statistics",
          "type": "directory",
          "path": "problems/statistics",
          "children": [
            {
              "name": "cost-per-participant.md",
              "type": "file",
              "path": "problems/statistics/cost-per-participant.md",
              "children": [],
              "metadata": {
                "number": "$41k",
                "textFollowingNumber": "cost per participant in traditional clinical trials",
                "title": "Clinical Trials Cost $41,413 Per Trial Participant",
                "description": "The cost per participant in clinical trials is a staggering $41,413",
                "emoji": "üë•",
                "featuredImage": "cost-per-participant.jpg",
                "source": "https://clinicalresearch.io/blog/running-a-study/cost-of-clinical-trials-breakdown/"
              }
            },
            {
              "name": "cost-per-treatment.md",
              "type": "file",
              "path": "problems/statistics/cost-per-treatment.md",
              "children": [],
              "metadata": {
                "number": "$1.6 Billion",
                "textFollowingNumber": "cost to develop a new treatment falls on patients",
                "title": "$1.6 Billion Per New Treatment Falls on Patients",
                "description": "The total cost passed to patients for each new medical treatment developed",
                "emoji": "üí∏",
                "featuredImage": "cost-per-treatment.jpg",
                "source": "https://www.genengnews.com/gen-edge/the-unbearable-cost-of-drug-development-deloitte-report-shows-15-jump-in-rd-to-2-3-billion/"
              }
            },
            {
              "name": "deaths-due-to-drug-lag.md",
              "type": "file",
              "path": "problems/statistics/deaths-due-to-drug-lag.md",
              "children": [],
              "metadata": {
                "number": "120,000 Deaths/Decade",
                "textFollowingNumber": "due to regulatory delays",
                "title": "120,000 US Deaths Per Decade Due to Drug Lag",
                "description": "Delays in FDA drug approvals compared to other countries result in up to 120,000 preventable deaths per decade",
                "emoji": "‚ò†Ô∏è",
                "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/us-swiss-life-expectancy-drug-approvals.png"
              }
            },
            {
              "name": "percent-excluded-from-trials.md",
              "type": "file",
              "path": "problems/statistics/percent-excluded-from-trials.md",
              "children": [],
              "metadata": {
                "number": "85%",
                "textFollowingNumber": "of patients are unable to participate in clinical trials",
                "title": "85% of Willing Participants Excluded from Trials",
                "description": "Clinical trials often exclude as much as 85% of patients so they don't tell us if the drug will work for the majority of patients.",
                "emoji": "üö´",
                "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/wellbutrin-effectiveness-small-sample-size.png"
              }
            },
            {
              "name": "percent-of-diseases-with-fda-approved-treatments.md",
              "type": "file",
              "path": "problems/statistics/percent-of-diseases-with-fda-approved-treatments.md",
              "children": [],
              "metadata": {
                "number": "95%",
                "textFollowingNumber": "of diseases have NO FDA-approved treatments",
                "title": "95% of Diseases Have NO FDA-Approved Treatments",
                "description": "Only 5% of diseases have FDA-approved treatments, leaving millions without effective therapies",
                "emoji": "üíä",
                "featuredImage": "fda-treatments.jpg"
              }
            },
            {
              "name": "treatments-tested.md",
              "type": "file",
              "path": "problems/statistics/treatments-tested.md",
              "children": [],
              "metadata": {
                "number": "166 billion",
                "textFollowingNumber": "potential treatments have not been tested",
                "title": "166 billion potential treatments have not been tested",
                "description": "The vast number of potential drug combinations that exist, compared to the limited number that have been tested",
                "emoji": "‚öõÔ∏è",
                "featuredImage": "treatments-tested.jpg"
              }
            },
            {
              "name": "uncured-people.md",
              "type": "file",
              "path": "problems/statistics/uncured-people.md",
              "children": [],
              "metadata": {
                "number": "2 Billion",
                "textFollowingNumber": "people are suffering from uncured diseases",
                "title": "2 Billion People With Uncured Diseases",
                "description": "An estimated two billion people worldwide live with chronic diseases and rare conditions that currently have no cure",
                "emoji": "üåç",
                "featuredImage": "uncured-people.jpg"
              }
            },
            {
              "name": "years-since-last-cure.md",
              "type": "file",
              "path": "problems/statistics/years-since-last-cure.md",
              "children": [],
              "metadata": {
                "number": "44 years",
                "textFollowingNumber": "since we last cured a disease",
                "title": "44 Years Since Last Cure",
                "description": "The medical research community has not discovered a complete cure for any disease since 1980",
                "emoji": "üß´",
                "featuredImage": "years-since-last-cure.jpg"
              }
            }
          ]
        },
        {
          "name": "trials-often-arent-representative-of-real-patients.md",
          "type": "file",
          "path": "problems/trials-often-arent-representative-of-real-patients.md",
          "children": [],
          "metadata": {
            "title": "Trials Often Aren't Representative of Real Patients",
            "description": "Clinical trials often exclude as much as 85% of patients so they don't tell us if the drug will work for the majority of patients.",
            "emoji": "ü•∏",
            "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/wellbutrin-effectiveness-small-sample-size.png"
          }
        },
        {
          "name": "unpatentable-treatments.md",
          "type": "file",
          "path": "problems/unpatentable-treatments.md",
          "children": [],
          "metadata": {
            "description": "We still know next to nothing about the long-term effects of 99.9% of the 4 pounds of over 7,000 different synthetic or natural chemicals you consume every day.",
            "emoji": "ü•´",
            "title": "No Data on Unpatentable Molecules",
            "tags": "clinical-trials, unpatentable-molecules, off-patent-treatments, orphan-diseases, pharmaceutical-research",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:55:54.489Z",
            "dateCreated": "2025-02-12T16:55:54.489Z"
          }
        },
        {
          "name": "unrepresentative-participants.md",
          "type": "file",
          "path": "problems/unrepresentative-participants.md",
          "children": [],
          "metadata": {
            "description": "Phase III clinical trials are often designed to exclude a vast majority of the population of interest.",
            "emoji": "üë•",
            "title": "Trials Often Aren't Representative of Real Patients",
            "tags": "clinical-trials, external-validity, generalizability, mental-health, eligibility-criteria",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-29T02:10:38.403Z",
            "dateCreated": "2022-07-22T19:04:16.586Z"
          }
        },
        {
          "name": "we-know-nothing.md",
          "type": "file",
          "path": "problems/we-know-nothing.md",
          "children": [],
          "metadata": {
            "title": "We Know Next to Nothing",
            "description": "There are thousands of diseases and trillions of compounds with drug-like properties, but we've only studied 0.000000002% of potential treatments so far.",
            "emoji": "‚ùì",
            "featuredImage": "https://static.crowdsourcingcures.org/dfda/assets/number-of-molecules-with-drug-like-properties.png"
          }
        },
        {
          "name": "we-only-know-the-effects-of-0000000002-of-potential-therapies.md",
          "type": "file",
          "path": "problems/we-only-know-the-effects-of-0000000002-of-potential-therapies.md",
          "children": [],
          "metadata": {
            "description": "There are as many untested compounds with drug-like properties as there are atoms in the solar system (166 billion).",
            "emoji": "üî¨",
            "title": "‚ùì We Only Know The Effects of 0.000000002% of Potential Therapies",
            "tags": "medical-research, diseases, drug-compounds, scientific-method",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-29T02:10:00.109Z",
            "dateCreated": "2022-07-22T19:04:21.179Z"
          }
        }
      ]
    },
    {
      "name": "proposals",
      "type": "directory",
      "path": "proposals",
      "children": [
        {
          "name": "dfda-act.md",
          "type": "file",
          "path": "proposals/dfda-act.md",
          "title": "üí° The Decentralized FDA",
          "children": [
            {
              "path": "economic-models/blueprint-gas.md",
              "title": "Blueprint for a World Without Disease"
            },
            {
              "path": "architecture/blueprint-high-level.md",
              "title": "Framework for a World Without Disease"
            },
            {
              "path": "architecture/blueprint-sitemap.md",
              "title": "Blueprint for a World Without Disease"
            },
            {
              "path": "strategy/blueprint-strategy.md",
              "title": "Strategy for a World Without Disease"
            },
            {
              "path": "strategy/blueprint-summary.md",
              "title": "Creating a World Without Disease"
            },
            {
              "path": "architecture/blueprint.md",
              "title": "Creating a World Without Disease"
            }
          ],
          "metadata": {
            "description": "80Xing medical progress by giving all patients the right to effortlessly participate in global decentralized clinical trials üíä",
            "published": true,
            "date": "2024-07-28T16:52:11.076Z",
            "tags": "overview",
            "editor": "markdown",
            "dateCreated": "2023-11-24T22:24:09.275Z"
          }
        },
        {
          "name": "health-savings-sharing.md",
          "type": "file",
          "path": "proposals/health-savings-sharing.md",
          "children": [],
          "metadata": {
            "description": "A program aiming to reduce healthcare costs by incentivizing cures and preventative therapies for chronic diseases.",
            "emoji": "üåü",
            "title": "50/50 Health Savings Sharing Program",
            "tags": "healthcare, cost-reduction, cures, preventative-therapies, chronic-diseases",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:56:08.061Z",
            "dateCreated": "2025-02-12T16:56:08.061Z"
          }
        },
        {
          "name": "use-github-for-task-management.md",
          "type": "file",
          "path": "proposals/use-github-for-task-management.md",
          "children": [],
          "metadata": {
            "description": "Explanation of using GitHub issues for task management with benefits like universal searchability, prioritization, expertise filtering, and notifications.",
            "emoji": "üìã",
            "title": "use-github-for-task-management",
            "tags": "github, task-management, project-management, crowdsourcing, searchability",
            "published": false,
            "editor": "markdown",
            "date": "2022-08-25T20:09:14.553Z",
            "dateCreated": "2022-07-27T20:33:14.760Z"
          }
        }
      ]
    },
    {
      "name": "reference",
      "type": "directory",
      "path": "reference",
      "children": [
        {
          "name": "12-references.md",
          "type": "file",
          "path": "reference/12-references.md",
          "children": [],
          "metadata": {
            "description": "Compilation of references and resources related to FDA spending, drug approvals, economic data, and regulatory impact",
            "emoji": "üìö",
            "title": "FDA References and Data Resources",
            "tags": "fda, spending, drug-approvals, economic-data, regulation",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:56:25.222Z",
            "dateCreated": "2025-02-12T16:56:25.222Z"
          }
        },
        {
          "name": "Research-and-Development-in-the-Pharmaceutical-Industry.md",
          "type": "file",
          "path": "reference/Research-and-Development-in-the-Pharmaceutical-Industry.md",
          "children": [],
          "metadata": {
            "description": "Analysis of pharmaceutical industry's research and development spending and its outcomes, including the increase in new drug approvals.",
            "emoji": "üî¨",
            "title": "Pharmaceutical R&D Spending and Outcomes",
            "tags": "pharmaceuticals, R&D, drug-development, industry-analysis",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:04.546Z",
            "dateCreated": "2025-02-12T20:29:04.546Z"
          }
        },
        {
          "name": "cost-barriers",
          "type": "directory",
          "path": "reference/cost-barriers",
          "children": [
            {
              "name": "21-data-sources.md",
              "type": "file",
              "path": "reference/cost-barriers/21-data-sources.md",
              "children": [],
              "metadata": {
                "description": "Overview of data sources used in constructing an operational model of clinical trial decision-making, including literature, expert interviews, FDA hearings, and Medidata Solutions databases.",
                "emoji": "üìö",
                "title": "Data Sources for Clinical Trial Decision-Making Model",
                "tags": "clinical-trials, data-sources, FDA, research-methodology, Medidata-Solutions",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:56:28.848Z",
                "dateCreated": "2025-02-12T16:56:28.848Z"
              }
            },
            {
              "name": "211-publically-available-literature.md",
              "type": "file",
              "path": "reference/cost-barriers/211-publically-available-literature.md",
              "children": [],
              "metadata": {
                "description": "Overview of publically available literature used to define components of the pharmaceutical decision-making process model, including sources like MIT and CTTI.",
                "emoji": "üìö",
                "title": "Publically Available Literature on Pharmaceutical Decision-Making",
                "tags": "literature-review, pharmaceuticals, decision-making, MIT, CTTI",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:56:32.278Z",
                "dateCreated": "2025-02-12T16:56:32.278Z"
              }
            },
            {
              "name": "212-discussions-with-experts-fda-personnel-drug-sponsors-contract-research-organizations-cros-and-academic-clinical-research-centers.md",
              "type": "file",
              "path": "reference/cost-barriers/212-discussions-with-experts-fda-personnel-drug-sponsors-contract-research-organizations-cros-and-academic-clinical-research-centers.md",
              "children": [],
              "metadata": {
                "description": "Details of discussions with experts, FDA personnel, drug sponsors, CROs, and academic research centers to understand the decision process in drug development.",
                "emoji": "üë•",
                "title": "Discussions on Drug Development Decision Processes",
                "tags": "drug-development, FDA, CROs, academic-research-centers, industry-experts",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:56:35.812Z",
                "dateCreated": "2025-02-12T16:56:35.812Z"
              }
            },
            {
              "name": "213-medidata-solutions-databases.md",
              "type": "file",
              "path": "reference/cost-barriers/213-medidata-solutions-databases.md",
              "children": [],
              "metadata": {
                "description": "Overview of Medidata Solutions databases used for clinical trial cost analysis, including PICAS, CROCAS, and Insights.",
                "emoji": "üìä",
                "title": "Medidata Solutions Databases for Clinical Trial Costs",
                "tags": "clinical-trials, costs, databases, Medidata Solutions, PICAS, CROCAS, Insights",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:56:39.403Z",
                "dateCreated": "2025-02-12T16:56:39.403Z"
              }
            },
            {
              "name": "22-conceptual-framework.md",
              "type": "file",
              "path": "reference/cost-barriers/22-conceptual-framework.md",
              "children": [],
              "metadata": {
                "description": "Conceptual framework for modeling clinical trial decision-making using a decision tree approach from the perspective of a revenue-maximizing sponsor.",
                "emoji": "üìä",
                "title": "Conceptual Framework for Clinical Trial Decision-Making",
                "tags": "clinical-trials, decision-making, modeling, sponsors, risk",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:56:42.726Z",
                "dateCreated": "2025-02-12T16:56:42.726Z"
              }
            },
            {
              "name": "23-operational-model.md",
              "type": "file",
              "path": "reference/cost-barriers/23-operational-model.md",
              "children": [],
              "metadata": {
                "description": "An operational model developed in Microsoft Excel for clinical trial cost scenario analysis with a guided user interface in Visual Basic.",
                "emoji": "üìä",
                "title": "Operational Model for Clinical Trial Cost Analysis",
                "tags": "clinical-trials, cost-analysis, operational-model, microsoft-excel, visual-basic",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T16:56:46.027Z",
                "dateCreated": "2025-02-12T16:56:46.027Z"
              }
            },
            {
              "name": "24-model-parameters.md",
              "type": "file",
              "path": "reference/cost-barriers/24-model-parameters.md",
              "children": [],
              "metadata": {
                "description": "Details on the parameters required for a clinical trial cost/decision-making model, including phase durations, success probabilities, expected revenues, and discount rates.",
                "emoji": "‚öôÔ∏è",
                "title": "Model Parameters for Clinical Trial Cost Analysis",
                "tags": "clinical-trials, model-parameters, cost-analysis, pharmaceutical-research",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:21.923Z",
                "dateCreated": "2025-02-12T20:26:21.923Z"
              }
            },
            {
              "name": "31-costs-by-therapeutic-area.md",
              "type": "file",
              "path": "reference/cost-barriers/31-costs-by-therapeutic-area.md",
              "children": [],
              "metadata": {
                "description": "Analysis of clinical trial costs across different therapeutic areas and phases",
                "emoji": "üìä",
                "title": "Clinical Trial Costs by Therapeutic Area",
                "tags": "clinical-trials, costs, therapeutic-areas, phases",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:24.787Z",
                "dateCreated": "2025-02-12T20:26:24.787Z"
              }
            },
            {
              "name": "32-costs-by-trial-phase.md",
              "type": "file",
              "path": "reference/cost-barriers/32-costs-by-trial-phase.md",
              "children": [],
              "metadata": {
                "description": "Analysis of clinical trial costs by phase using weighted mean and standard deviation",
                "emoji": "üìä",
                "title": "Clinical Trial Costs by Phase",
                "tags": "clinical-trials, cost-analysis, phases, weighted-mean, standard-deviation",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:27.757Z",
                "dateCreated": "2025-02-12T20:26:27.757Z"
              }
            },
            {
              "name": "33-costs-by-cost-component.md",
              "type": "file",
              "path": "reference/cost-barriers/33-costs-by-cost-component.md",
              "children": [],
              "metadata": {
                "description": "Detailed breakdown of clinical trial costs by cost component across therapeutic areas and trial phases",
                "emoji": "üìä",
                "title": "Clinical Trial Costs by Cost Component",
                "tags": "clinical-trials, cost-analysis, therapeutic-areas, trial-phases",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:30.722Z",
                "dateCreated": "2025-02-12T20:26:30.722Z"
              }
            },
            {
              "name": "34-conclusions.md",
              "type": "file",
              "path": "reference/cost-barriers/34-conclusions.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the key drivers of costs in clinical trials across different therapeutic areas and phases, highlighting specific high-cost areas.",
                "emoji": "üìä",
                "title": "Key Drivers of Clinical Trial Costs by Therapeutic Area and Phase",
                "tags": "clinical-trials, cost-analysis, therapeutic-areas, phases",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:34.037Z",
                "dateCreated": "2025-02-12T20:26:34.037Z"
              }
            },
            {
              "name": "41-high-financial-cost.md",
              "type": "file",
              "path": "reference/cost-barriers/41-high-financial-cost.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the high financial costs associated with conducting clinical research and drug development",
                "emoji": "üí∞",
                "title": "High Financial Cost of Clinical Research and Drug Development",
                "tags": "clinical-research, drug-development, costs, financial-barriers",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:37.027Z",
                "dateCreated": "2025-02-12T20:26:37.027Z"
              }
            },
            {
              "name": "42-lengthy-timelines.md",
              "type": "file",
              "path": "reference/cost-barriers/42-lengthy-timelines.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the lengthy timelines involved in clinical trials and drug development, including increases in development and regulatory cycle times.",
                "emoji": "‚è≥",
                "title": "Lengthy Timelines in Clinical Trials and Drug Development",
                "tags": "clinical-trials, drug-development, regulatory-process, timelines",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:40.234Z",
                "dateCreated": "2025-02-12T20:26:40.234Z"
              }
            },
            {
              "name": "43-difficulties-in-recruiting-and-retaining-participants.md",
              "type": "file",
              "path": "reference/cost-barriers/43-difficulties-in-recruiting-and-retaining-participants.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the challenges in recruiting and retaining participants for clinical trials, including factors like study size and competition among drugs.",
                "emoji": "üë•",
                "title": "Difficulties in Recruiting and Retaining Clinical Trial Participants",
                "tags": "clinical-trials, patient-recruitment, barriers, pharmaceuticals, biotechnology",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:43.708Z",
                "dateCreated": "2025-02-12T20:26:43.708Z"
              }
            },
            {
              "name": "44-increasing-competition-for-qualified-investigators-and-sites.md",
              "type": "file",
              "path": "reference/cost-barriers/44-increasing-competition-for-qualified-investigators-and-sites.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the competition for qualified investigators and clinical trial sites, highlighting the challenges faced by sponsors in securing top researchers.",
                "emoji": "üë•",
                "title": "Competition for Qualified Investigators and Sites",
                "tags": "clinical-trials, investigators, sites, competition, sponsors",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:46.891Z",
                "dateCreated": "2025-02-12T20:26:46.891Z"
              }
            },
            {
              "name": "45-regulatory-and-administrative-barriers.md",
              "type": "file",
              "path": "reference/cost-barriers/45-regulatory-and-administrative-barriers.md",
              "children": [],
              "metadata": {
                "description": "Analysis of regulatory and administrative barriers in clinical research, including their origins and impact on the clinical trials process.",
                "emoji": "‚ö†Ô∏è",
                "title": "Regulatory and Administrative Barriers in Clinical Research",
                "tags": "regulations, clinical-research, administrative-barriers, safety",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:50.097Z",
                "dateCreated": "2025-02-12T20:26:50.097Z"
              }
            },
            {
              "name": "451-regulations-protecting-human-research-subjects-and-their-privacy.md",
              "type": "file",
              "path": "reference/cost-barriers/451-regulations-protecting-human-research-subjects-and-their-privacy.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the challenges in ethical review processes for human research, focusing on IRB responsibilities and multisite trial approvals",
                "emoji": "üîç",
                "title": "Regulations Protecting Human Research Subjects and Privacy",
                "tags": "IRB, regulations, human-research, ethics, multisite-trials",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:53.574Z",
                "dateCreated": "2025-02-12T20:26:53.574Z"
              }
            },
            {
              "name": "452-safety-reporting-requirements-for-investigational-new-drugs-inds-and-biologics-21-cfr-312.md",
              "type": "file",
              "path": "reference/cost-barriers/452-safety-reporting-requirements-for-investigational-new-drugs-inds-and-biologics-21-cfr-312.md",
              "children": [],
              "metadata": {
                "description": "Safety reporting requirements for Investigational New Drugs (INDs) and biologics as per 21 CFR 312, including definitions of adverse events.",
                "emoji": "‚ö†Ô∏è",
                "title": "Safety Reporting Requirements for INDs and Biologics",
                "tags": "ind, biologics, adverse-events, safety-reporting, fda-regulations",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:26:57.327Z",
                "dateCreated": "2025-02-12T20:26:57.328Z"
              }
            },
            {
              "name": "453-regulations-for-multiple-jurisdictions.md",
              "type": "file",
              "path": "reference/cost-barriers/453-regulations-for-multiple-jurisdictions.md",
              "children": [],
              "metadata": {
                "description": "Overview of the complexities and challenges in complying with regulations for clinical trials across multiple jurisdictions, including federal, state, local, and international requirements.",
                "emoji": "üåç",
                "title": "Regulations for Multi-Jurisdiction Clinical Trials",
                "tags": "clinical-trials, regulations, compliance, international, EU",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:00.722Z",
                "dateCreated": "2025-02-12T20:27:00.722Z"
              }
            },
            {
              "name": "454-conservative-regulatory-climate.md",
              "type": "file",
              "path": "reference/cost-barriers/454-conservative-regulatory-climate.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the risk-averse regulatory climate at the FDA and its impact on drug development",
                "emoji": "üîí",
                "title": "FDA's Conservative Regulatory Climate",
                "tags": "fda, regulatory-climate, drug-development, risk-benefit-analysis",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:03.699Z",
                "dateCreated": "2025-02-12T20:27:03.699Z"
              }
            },
            {
              "name": "455-lack-of-clear-regulatory-pathways-and-guidance-for-some-therapeutic-areas.md",
              "type": "file",
              "path": "reference/cost-barriers/455-lack-of-clear-regulatory-pathways-and-guidance-for-some-therapeutic-areas.md",
              "children": [],
              "metadata": {
                "description": "Discussion on the lack of clear regulatory pathways and guidance for certain therapeutic areas, impacting FDA communication and expectations.",
                "emoji": "‚ö†Ô∏è",
                "title": "Lack of Clear Regulatory Pathways for Some Therapeutic Areas",
                "tags": "regulatory-pathways, fda-guidance, therapeutic-areas, clinical-research",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:07.107Z",
                "dateCreated": "2025-02-12T20:27:07.107Z"
              }
            },
            {
              "name": "456-barriers-related-to-the-review-process.md",
              "type": "file",
              "path": "reference/cost-barriers/456-barriers-related-to-the-review-process.md",
              "children": [],
              "metadata": {
                "description": "Analysis of barriers related to the FDA's review process, including resource constraints and concerns about reviewer authority.",
                "emoji": "üìù",
                "title": "Barriers in the FDA Review Process",
                "tags": "fda, review-process, regulatory-barriers, resource-constraints",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:10.229Z",
                "dateCreated": "2025-02-12T20:27:10.229Z"
              }
            },
            {
              "name": "46-drug-sponsor-imposed-barriers.md",
              "type": "file",
              "path": "reference/cost-barriers/46-drug-sponsor-imposed-barriers.md",
              "children": [],
              "metadata": {
                "description": "Analysis of drug sponsor-imposed barriers in clinical research, focusing on risk aversion and its impact on costs and delays.",
                "emoji": "üö´",
                "title": "Drug Sponsor-imposed Barriers in Clinical Research",
                "tags": "clinical-research, drug-sponsors, risk-aversion, costs, delays",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:13.712Z",
                "dateCreated": "2025-02-12T20:27:13.712Z"
              }
            },
            {
              "name": "461-administrative.md",
              "type": "file",
              "path": "reference/cost-barriers/461-administrative.md",
              "children": [],
              "metadata": {
                "description": "Analysis of administrative inefficiencies in drug companies, focusing on contract negotiation and internal review processes impacting clinical trials.",
                "emoji": "üìù",
                "title": "Administrative Inefficiencies in Drug Development",
                "tags": "drug-development, clinical-trials, administrative-processes, contracts, internal-review",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:17.038Z",
                "dateCreated": "2025-02-12T20:27:17.038Z"
              }
            },
            {
              "name": "462-study-design.md",
              "type": "file",
              "path": "reference/cost-barriers/462-study-design.md",
              "children": [],
              "metadata": {
                "description": "Discussion on enrollment restrictions in clinical trials and their impact on participant recruitment and trial completion rates.",
                "emoji": "üë•",
                "title": "Enrollment Restrictions in Clinical Trials",
                "tags": "clinical-trials, enrollment, eligibility-criteria, recruitment",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:20.093Z",
                "dateCreated": "2025-02-12T20:27:20.093Z"
              }
            },
            {
              "name": "463-data-and-site-monitoring.md",
              "type": "file",
              "path": "reference/cost-barriers/463-data-and-site-monitoring.md",
              "children": [],
              "metadata": {
                "description": "Analysis of data and site monitoring costs in clinical trials, focusing on the impact of source data verification practices.",
                "emoji": "üîç",
                "title": "Data and Site Monitoring Costs in Clinical Trials",
                "tags": "clinical-trials, data-monitoring, costs, source-data-verification, FDA-regulations",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:23.388Z",
                "dateCreated": "2025-02-12T20:27:23.388Z"
              }
            },
            {
              "name": "464-serious-adverse-events-saes-reporting-for-investigational-new-drugs-and-biologics-inds-21-cfr-312.md",
              "type": "file",
              "path": "reference/cost-barriers/464-serious-adverse-events-saes-reporting-for-investigational-new-drugs-and-biologics-inds-21-cfr-312.md",
              "children": [],
              "metadata": {
                "description": "Discussion on the reporting of Serious Adverse Events (SAEs) for Investigational New Drugs and Biologics under 21 CFR 312, including historical context and regulatory changes.",
                "emoji": "‚ö†Ô∏è",
                "title": "Serious Adverse Events Reporting for INDs",
                "tags": "adverse-events, regulatory-compliance, drug-development, biologics, INDs",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:27.377Z",
                "dateCreated": "2025-02-12T20:27:27.377Z"
              }
            },
            {
              "name": "47-disconnect-between-clinical-research-and-medical-care.md",
              "type": "file",
              "path": "reference/cost-barriers/47-disconnect-between-clinical-research-and-medical-care.md",
              "children": [],
              "metadata": {
                "description": "Analysis of the disconnect between clinical research and medical care, highlighting issues such as lack of community physician involvement, shortages of investigators and patients, high costs, and lengthy timelines.",
                "emoji": "üî¨",
                "title": "Disconnect Between Clinical Research and Medical Care",
                "tags": "clinical-research, medical-care, physicians, health-systems, barriers",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:31.009Z",
                "dateCreated": "2025-02-12T20:27:31.009Z"
              }
            },
            {
              "name": "48-barriers-at-academic-institutions.md",
              "type": "file",
              "path": "reference/cost-barriers/48-barriers-at-academic-institutions.md",
              "children": [],
              "metadata": {
                "description": "Discussion of barriers faced by drug sponsors when using academic institutions as clinical trial sites, including bureaucratic processes and lengthy timelines.",
                "emoji": "üìö",
                "title": "Barriers at Academic Institutions for Clinical Trials",
                "tags": "clinical-trials, academic-institutions, bureaucracy, drug-sponsors",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:34.398Z",
                "dateCreated": "2025-02-12T20:27:34.398Z"
              }
            },
            {
              "name": "49-barriers-related-to-the-globalization-of-clinical-research.md",
              "type": "file",
              "path": "reference/cost-barriers/49-barriers-related-to-the-globalization-of-clinical-research.md",
              "children": [],
              "metadata": {
                "description": "Discussion of barriers related to globalization in clinical research, including the shift of trial sites overseas and declining U.S.-based investigations.",
                "emoji": "üåç",
                "title": "Globalization Barriers in Clinical Research",
                "tags": "clinical-research, globalization, FDA-regulated, trial-sites, United-States",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:37.826Z",
                "dateCreated": "2025-02-12T20:27:37.826Z"
              }
            },
            {
              "name": "51-use-of-electronic-health-records-ehr.md",
              "type": "file",
              "path": "reference/cost-barriers/51-use-of-electronic-health-records-ehr.md",
              "children": [],
              "metadata": {
                "description": "Exploration of how Electronic Health Records (EHR) enhance clinical trial recruitment through systems like Clinical Trial Alerts, improving referral and enrollment rates.",
                "emoji": "üìã",
                "title": "Use of Electronic Health Records in Clinical Trials",
                "tags": "electronic-health-records, clinical-trials, recruitment, trial-costs",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:41.239Z",
                "dateCreated": "2025-02-12T20:27:41.239Z"
              }
            },
            {
              "name": "52-relaxing-trial-enrollment-restrictions.md",
              "type": "file",
              "path": "reference/cost-barriers/52-relaxing-trial-enrollment-restrictions.md",
              "children": [],
              "metadata": {
                "description": "Analysis of relaxing trial enrollment restrictions to improve patient recruitment and reduce clinical trial barriers",
                "emoji": "üë•",
                "title": "Relaxing Trial Enrollment Restrictions",
                "tags": "clinical-trials, patient-recruitment, enrollment-rates, eligibility-criteria",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:44.286Z",
                "dateCreated": "2025-02-12T20:27:44.286Z"
              }
            },
            {
              "name": "53-simplified-clinical-trial-protocols-and-reduced-amendments.md",
              "type": "file",
              "path": "reference/cost-barriers/53-simplified-clinical-trial-protocols-and-reduced-amendments.md",
              "children": [],
              "metadata": {
                "description": "Strategy to reduce clinical trial costs by simplifying protocols and minimizing avoidable amendments, potentially cutting data collection costs by 22.5%.",
                "emoji": "üìã",
                "title": "Simplified Clinical Trial Protocols and Reduced Amendments",
                "tags": "clinical-trials, cost-reduction, protocol-efficiency, data-collection",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:47.657Z",
                "dateCreated": "2025-02-12T20:27:47.657Z"
              }
            },
            {
              "name": "54-reduced-source-data-verification-sdv.md",
              "type": "file",
              "path": "reference/cost-barriers/54-reduced-source-data-verification-sdv.md",
              "children": [],
              "metadata": {
                "description": "Analysis of cost savings from reducing source data verification in clinical trials",
                "emoji": "üìä",
                "title": "Reduced Source Data Verification in Clinical Trials",
                "tags": "clinical-trials, source-data-verification, cost-savings, risk-based-approach",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:50.715Z",
                "dateCreated": "2025-02-12T20:27:50.715Z"
              }
            },
            {
              "name": "55-wider-use-of-mobile-technologies-such-as-electronic-data-capture-edc.md",
              "type": "file",
              "path": "reference/cost-barriers/55-wider-use-of-mobile-technologies-such-as-electronic-data-capture-edc.md",
              "children": [],
              "metadata": {
                "description": "Exploration of how Electronic Data Capture (EDC) can reduce clinical trial durations and costs",
                "emoji": "üì±",
                "title": "Wider Use of EDC in Clinical Trials",
                "tags": "edc, clinical-trials, technology, cost-efficiency",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:53.757Z",
                "dateCreated": "2025-02-12T20:27:53.757Z"
              }
            },
            {
              "name": "56-wider-use-of-lower-cost-facilities-andor-at-home-testing.md",
              "type": "file",
              "path": "reference/cost-barriers/56-wider-use-of-lower-cost-facilities-andor-at-home-testing.md",
              "children": [],
              "metadata": {
                "description": "Exploration of lower-cost facilities and at-home testing as methods to reduce clinical trial expenses and improve participant retention.",
                "emoji": "üè†",
                "title": "Lower-cost Facilities and At-home Testing in Clinical Trials",
                "tags": "clinical-trials, cost-reduction, at-home-testing, web-based-trials, participant-retention",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:27:57.233Z",
                "dateCreated": "2025-02-12T20:27:57.233Z"
              }
            },
            {
              "name": "57-priority-reviewpriority-review-vouchers.md",
              "type": "file",
              "path": "reference/cost-barriers/57-priority-reviewpriority-review-vouchers.md",
              "children": [],
              "metadata": {
                "description": "Explanation of Priority Review Vouchers as a policy option to incentivize development of treatments for neglected diseases",
                "emoji": "üìù",
                "title": "Priority Review Vouchers",
                "tags": "policy, neglected-diseases, fda, incentives, clinical-trials",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:28:00.521Z",
                "dateCreated": "2025-02-12T20:28:00.521Z"
              }
            },
            {
              "name": "58-improvements-in-fda-review-process-efficiency-and-more-frequent-and-timely-interactions-with-fda.md",
              "type": "file",
              "path": "reference/cost-barriers/58-improvements-in-fda-review-process-efficiency-and-more-frequent-and-timely-interactions-with-fda.md",
              "children": [],
              "metadata": {
                "description": "Analysis of FDA review process efficiency and the impact of advisory committee meetings on approval times",
                "emoji": "‚è≥",
                "title": "FDA Review Process Efficiency and Advisory Committee Impact",
                "tags": "fda-review-process, advisory-committee, approval-times, clinical-trials",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:28:03.619Z",
                "dateCreated": "2025-02-12T20:28:03.619Z"
              }
            },
            {
              "name": "59-conclusions.md",
              "type": "file",
              "path": "reference/cost-barriers/59-conclusions.md",
              "children": [],
              "metadata": {
                "description": "Evaluation of barrier mitigation strategies and their impacts on drug development costs and returns, with a focus on priority review vouchers and FDA review efficiency.",
                "emoji": "üìä",
                "title": "Barrier Mitigation Strategies in Drug Development",
                "tags": "drug-development, barrier-mitigation, FDA, priority-review-vouchers, costs",
                "published": true,
                "editor": "markdown",
                "date": "2025-02-12T20:28:07.055Z",
                "dateCreated": "2025-02-12T20:28:07.055Z"
              }
            },
            {
              "name": "executive-summary",
              "type": "directory",
              "path": "reference/cost-barriers/executive-summary",
              "children": [
                {
                  "name": "e1-clinical-trial-decision-making-model.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e1-clinical-trial-decision-making-model.md",
                  "children": [],
                  "metadata": {
                    "description": "A stylized decision tree model for drug sponsors formulating clinical trials, focusing on revenue maximization and incorporating therapeutic area, market size, clinical stage costs, and success probabilities.",
                    "emoji": "üìä",
                    "title": "Clinical Trial Decision-making Model",
                    "tags": "clinical-trials, decision-making, drug-development, revenue-modeling, cost-analysis",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:10.650Z",
                    "dateCreated": "2025-02-12T20:28:10.650Z"
                  }
                },
                {
                  "name": "e2-analysis-of-costs.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e2-analysis-of-costs.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of clinical trial costs by therapeutic area and phase using data from Medidata Solutions",
                    "emoji": "üìä",
                    "title": "Clinical Trial Cost Analysis by Therapeutic Area and Phase",
                    "tags": "clinical-trials, cost-analysis, therapeutic-areas, phases",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:13.700Z",
                    "dateCreated": "2025-02-12T20:28:13.700Z"
                  }
                },
                {
                  "name": "e3-barriers-to-clinical-trials.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e3-barriers-to-clinical-trials.md",
                  "children": [],
                  "metadata": {
                    "description": "Key obstacles to conducting clinical trials in the United States including high costs, lengthy time frames, recruitment challenges, workforce issues, sponsor-imposed barriers, regulatory hurdles, and globalization-related issues.",
                    "emoji": "üöß",
                    "title": "Barriers to Clinical Trials in the United States",
                    "tags": "clinical-trials, barriers, regulatory, recruitment, costs",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:17.363Z",
                    "dateCreated": "2025-02-12T20:28:17.363Z"
                  }
                },
                {
                  "name": "e31-high-financial-cost.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e31-high-financial-cost.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of the high financial costs associated with bringing a new drug to market, ranging from $161 million to $2 billion, and the impact of shifting research focus towards chronic diseases.",
                    "emoji": "üìà",
                    "title": "High Financial Costs in Drug Development",
                    "tags": "drug-development, costs, chronic-diseases, pharmaceutical-industry",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:21.024Z",
                    "dateCreated": "2025-02-12T20:28:21.024Z"
                  }
                },
                {
                  "name": "e32-lengthy-timelines.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e32-lengthy-timelines.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of lengthy timelines in clinical trials and their impact on costs and revenues",
                    "emoji": "‚è≥",
                    "title": "Lengthy Timelines in Clinical Trials",
                    "tags": "clinical-trials, timelines, costs, efficiency, revenues",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:23.997Z",
                    "dateCreated": "2025-02-12T20:28:23.997Z"
                  }
                },
                {
                  "name": "e33-difficulties-in-recruiting-and-retaining-participants.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e33-difficulties-in-recruiting-and-retaining-participants.md",
                  "children": [],
                  "metadata": {
                    "description": "Discussion of challenges in recruiting and retaining participants for clinical trials, including competition for limited patient pools and site selection based on investigator location.",
                    "emoji": "üë•",
                    "title": "Difficulties in Recruiting and Retaining Clinical Trial Participants",
                    "tags": "clinical-trials, recruitment, patient-participation, rare-diseases",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:27.527Z",
                    "dateCreated": "2025-02-12T20:28:27.527Z"
                  }
                },
                {
                  "name": "e34-increasing-competition-for-qualified-investigators-and-sites.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e34-increasing-competition-for-qualified-investigators-and-sites.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of the challenges in increasing competition for qualified investigators and clinical trial sites, including shortages, attrition rates, and difficulties for new sites.",
                    "emoji": "üë©‚Äçüî¨",
                    "title": "Increasing Competition for Qualified Investigators and Sites",
                    "tags": "clinical-trials, investigators, sites, shortages, competition",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:30.927Z",
                    "dateCreated": "2025-02-12T20:28:30.927Z"
                  }
                },
                {
                  "name": "e35-regulatory-and-administrative-barriers.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e35-regulatory-and-administrative-barriers.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of regulatory and administrative barriers in clinical research, including IRB approval, informed consent, and patient privacy under HIPAA.",
                    "emoji": "üîí",
                    "title": "Regulatory and Administrative Barriers in Clinical Research",
                    "tags": "regulations, clinical-research, irb, informed-consent, hipaa",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:34.291Z",
                    "dateCreated": "2025-02-12T20:28:34.291Z"
                  }
                },
                {
                  "name": "e36-drug-sponsor-imposed-barriers.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e36-drug-sponsor-imposed-barriers.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of drug sponsor-imposed barriers in clinical trials, including risk aversion, enrollment restrictions, and complex protocols.",
                    "emoji": "üö´",
                    "title": "Drug Sponsor-Imposed Barriers in Clinical Trials",
                    "tags": "clinical-trials, drug-sponsors, barriers, enrollment, protocols",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:37.613Z",
                    "dateCreated": "2025-02-12T20:28:37.613Z"
                  }
                },
                {
                  "name": "e37-disconnect-between-clinical-research-and-medical-care.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e37-disconnect-between-clinical-research-and-medical-care.md",
                  "children": [],
                  "metadata": {
                    "description": "Discussion on the disconnect between clinical research and medical care, focusing on community physician involvement and research training.",
                    "emoji": "ü©∫",
                    "title": "Disconnect Between Clinical Research and Medical Care",
                    "tags": "clinical-research, medical-care, physicians, training",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:40.666Z",
                    "dateCreated": "2025-02-12T20:28:40.666Z"
                  }
                },
                {
                  "name": "e38-barriers-at-academic-institutions.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e38-barriers-at-academic-institutions.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of barriers faced by academic institutions in conducting clinical trials, including regulatory extremes and low prioritization of clinical research.",
                    "emoji": "üìö",
                    "title": "Barriers to Clinical Trials at Academic Institutions",
                    "tags": "clinical-trials, academic-institutions, regulatory-barriers, research-prioritization",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:43.984Z",
                    "dateCreated": "2025-02-12T20:28:43.984Z"
                  }
                },
                {
                  "name": "e39-barriers-related-to-the-globalization-of-clinical-research.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e39-barriers-related-to-the-globalization-of-clinical-research.md",
                  "children": [],
                  "metadata": {
                    "description": "Discussion of barriers related to globalization of clinical research, including ethical, scientific, and logistical challenges.",
                    "emoji": "üåç",
                    "title": "Barriers in Global Clinical Research",
                    "tags": "clinical-research, globalization, barriers, multicenter-trials",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:47.065Z",
                    "dateCreated": "2025-02-12T20:28:47.065Z"
                  }
                },
                {
                  "name": "e4-analysis-of-barriers-to-clinical-trials.md",
                  "type": "file",
                  "path": "reference/cost-barriers/executive-summary/e4-analysis-of-barriers-to-clinical-trials.md",
                  "children": [],
                  "metadata": {
                    "description": "Analysis of barriers to clinical trials and strategies for mitigation, including use of EHR, simplified protocols, reduced SDV, mobile technologies, lower-cost facilities, Priority Review vouchers, and FDA process improvements.",
                    "emoji": "üìä",
                    "title": "Barriers to Clinical Trials and Mitigation Strategies",
                    "tags": "clinical-trials, barriers, FDA, policy, cost-efficiency",
                    "published": true,
                    "editor": "markdown",
                    "date": "2025-02-12T20:28:50.817Z",
                    "dateCreated": "2025-02-12T20:28:50.817Z"
                  }
                }
              ]
            }
          ]
        },
        {
          "name": "data-storage-costs.md",
          "type": "file",
          "path": "reference/data-storage-costs.md",
          "children": [],
          "metadata": {
            "title": "Data Storage Costs for Decentralized Clinical Trials",
            "description": "Analysis of per-patient data storage costs in a decentralized FDA platform",
            "emoji": "üíæ"
          }
        },
        {
          "name": "historical-evidence-supporting-decentralized-efficacy-trials.md",
          "type": "file",
          "path": "reference/historical-evidence-supporting-decentralized-efficacy-trials.md",
          "children": [],
          "metadata": {
            "description": "Large scale efficacy-trials based on real-world evidence have historically led to better health outcomes than current pharmaceutical industry-driven randomized controlled trials.",
            "emoji": "üìò",
            "title": "Historical Evidence for Decentralized Efficacy Trials",
            "tags": "historical-evidence, decentralized-trials, real-world-evidence, health-outcomes, clinical-trials",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:28:54.306Z",
            "dateCreated": "2025-02-12T20:28:54.306Z"
          }
        },
        {
          "name": "historical-evidence-supporting-real-wold-efficacy-trials.md",
          "type": "file",
          "path": "reference/historical-evidence-supporting-real-wold-efficacy-trials.md",
          "children": [],
          "metadata": {
            "description": "Large scale efficacy-trials based on real-world evidence have historically led to better health outcomes than current pharmaceutical industry-driven randomized controlled trials.",
            "emoji": "üìö",
            "title": "üìò Historical Evidence Supporting Real-World Efficacy Trials",
            "tags": "efficacy-trials, historical-analysis, health-outcomes, safety-trials",
            "published": true,
            "editor": "markdown",
            "date": "2024-04-16T17:05:14.088Z",
            "dateCreated": "2023-11-07T19:00:41.120Z"
          }
        },
        {
          "name": "history-of-medical-regulation-and-clinical-research.md",
          "type": "file",
          "path": "reference/history-of-medical-regulation-and-clinical-research.md",
          "children": [],
          "metadata": {
            "description": "Historical analysis of efficacy trials and their impact on health outcomes compared to modern pharmaceutical trials",
            "emoji": "üìö",
            "title": "History of Medical Regulation and Clinical Research",
            "tags": "clinical-trials, history, real-world-evidence, health-outcomes",
            "published": true,
            "editor": "markdown",
            "image": "https://static.crowdsourcingcures.org/img/life-expectancy-historical.jpg",
            "date": "2023-10-26T19:37:36.565Z",
            "dateCreated": "2023-10-26T19:37:36.565Z"
          }
        },
        {
          "name": "impact-of-innovative-medicines-on-life-expectancy.md",
          "type": "file",
          "path": "reference/impact-of-innovative-medicines-on-life-expectancy.md",
          "children": [],
          "metadata": {
            "description": "If no new drugs had been launched after 1981, the number of years of life lost would have been 2.16 times higher.",
            "emoji": "üî¨",
            "title": "üìà Impact of Innovative Medicines on Life Expectancy",
            "tags": "pharmaceuticals, innovation, mortality, cancer, healthcare",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-29T03:35:13.588Z",
            "dateCreated": "2022-07-22T19:05:17.419Z"
          }
        },
        {
          "name": "nih-recover-initiative.md",
          "type": "file",
          "path": "reference/nih-recover-initiative.md",
          "children": [],
          "metadata": {
            "description": "",
            "title": "Efficiency of NIH Research Funding vs. an Automated Decentralized Trial Platform",
            "tags": "decentralized-trials, real-world-evidence, clinical-trials",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:28:54.306Z",
            "dateCreated": "2025-02-12T20:28:54.306Z"
          }
        },
        {
          "name": "otc-drugs.md",
          "type": "file",
          "path": "reference/otc-drugs.md",
          "children": [],
          "metadata": {
            "description": "Table estimating the number of lives that could be saved annually by increasing accessibility to certain drugs",
            "emoji": "ü©∫",
            "title": "Estimated Lives Saved by Increased Drug Accessibility",
            "tags": "public-health, drugs, lives-saved, accessibility",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:55:14.923Z",
            "dateCreated": "2025-02-12T16:55:14.923Z"
          }
        },
        {
          "name": "pragmatic-trials.md",
          "type": "file",
          "path": "reference/pragmatic-trials.md",
          "children": [],
          "metadata": {
            "title": "Pragmatic vs Explanatory Trials: A Quantitative Analysis",
            "description": "A comparison of pragmatic and explanatory trials focusing on cost, time, and real-world applicability.",
            "published": true,
            "date": "2025-02-27T07:36:34.941Z",
            "tags": "clinical-trials, research-methodology, healthcare-innovation, trial-design",
            "editor": "markdown",
            "dateCreated": "2025-02-27T07:36:34.941Z"
          }
        },
        {
          "name": "recovery-trial.md",
          "type": "file",
          "path": "reference/recovery-trial.md",
          "children": [],
          "metadata": {
            "description": "Exploration of how the RECOVERY trial reduced clinical research costs and a proposal for scaling its approach with a decentralized platform",
            "emoji": "üî¨",
            "title": "Scaling RECOVERY Trial Efficiency with Decentralized Platforms",
            "tags": "clinical-trials, decentralized-platforms, cost-efficiency, RECOVERY-trial",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:43.625Z",
            "dateCreated": "2025-02-12T20:29:43.625Z"
          }
        },
        {
          "name": "references.md",
          "type": "file",
          "path": "reference/references.md",
          "children": [],
          "metadata": {
            "description": "Compilation of resources and data related to FDA spending, approvals, economic indicators, and historical analysis",
            "emoji": "üìä",
            "title": "References",
            "tags": "fda, spending, approvals, economic-indicators, historical-data",
            "published": true,
            "editor": "markdown",
            "date": "2022-07-26T01:14:19.159Z",
            "dateCreated": "2022-07-22T19:04:25.725Z"
          }
        },
        {
          "name": "value-of-new-treatment.md",
          "type": "file",
          "path": "reference/value-of-new-treatment.md",
          "children": [],
          "metadata": {
            "title": "Economic Value of Accelerating Medical Progress Through New Therapies",
            "description": "Estimates the economic value of new therapies, including their market valuation and potential impact when accelerating medical progress by 80X.",
            "published": true,
            "date": "2025-02-20T05:43:26.476Z",
            "tags": "medical-progress, economic-value, new-therapies, drug-development",
            "editor": "markdown",
            "dateCreated": "2025-02-20T05:43:26.477Z"
          }
        }
      ]
    },
    {
      "name": "reference-databases",
      "type": "directory",
      "path": "reference-databases",
      "children": [
        {
          "name": "README.md",
          "type": "file",
          "path": "reference-databases/README.md",
          "children": [],
          "metadata": {
            "description": "An overview of the reference databases integrated by the Unified Health API to accelerate clinical research, including nutritional supplements, units of measurement, medications, symptoms and diseases, biomarkers, clinical trials, and medical codes.",
            "emoji": "üìñ",
            "title": "README",
            "tags": "health-data, clinical-research, databases, unified-api, medical-codes",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T19:46:02.884Z",
            "dateCreated": "2022-07-27T21:23:26.498Z"
          }
        },
        {
          "name": "biomarker-databases.md",
          "type": "file",
          "path": "reference-databases/biomarker-databases.md",
          "children": [],
          "metadata": {
            "description": "Logical Observation Identifiers Names and Codes",
            "emoji": "ü©∏",
            "title": "biomarker-databases",
            "tags": "biomarkers, LOINC, laboratory-tests, health-information, databases",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T19:53:52.826Z",
            "dateCreated": "2022-07-27T21:23:32.004Z"
          }
        },
        {
          "name": "diseases.md",
          "type": "file",
          "path": "reference-databases/diseases.md",
          "children": [],
          "metadata": {
            "description": "International Classification of Diseases, 10th revision (ICD-10)",
            "emoji": "ü©∫",
            "title": "diseases",
            "tags": "diseases, classification, ICD-10, government",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T19:59:14.867Z",
            "dateCreated": "2022-07-27T21:23:37.304Z"
          }
        },
        {
          "name": "food-databases.md",
          "type": "file",
          "path": "reference-databases/food-databases.md",
          "children": [],
          "metadata": {
            "description": "Food and Nutrient Database for Dietary Studies (FNDDS)",
            "emoji": "ü•ë",
            "title": "food-databases",
            "tags": "food-databases, nutrition, USDA, FoodData-Central, FNDDS",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T20:04:14.495Z",
            "dateCreated": "2022-07-27T21:23:42.390Z"
          }
        },
        {
          "name": "medication-databases.md",
          "type": "file",
          "path": "reference-databases/medication-databases.md",
          "children": [],
          "metadata": {
            "description": "RxNorm and MeDRA",
            "emoji": "üíä",
            "title": "medication-databases",
            "tags": "databases, RxNorm, MedDRA, drugs, regulatory",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T20:04:51.436Z",
            "dateCreated": "2022-07-27T21:23:47.640Z"
          }
        },
        {
          "name": "supplement-databases.md",
          "type": "file",
          "path": "reference-databases/supplement-databases.md",
          "children": [],
          "metadata": {
            "description": "Dietary Supplement Ingredients",
            "emoji": "üíä",
            "title": "supplement-databases",
            "tags": "supplements, databases, DSLD, DSID, nutrient-intake, data",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T21:50:07.113Z",
            "dateCreated": "2022-07-27T21:23:53.126Z"
          }
        },
        {
          "name": "units.md",
          "type": "file",
          "path": "reference-databases/units.md",
          "children": [],
          "metadata": {
            "description": "Introduction to UCUM, a code system for units of measure used in international science",
            "emoji": "üìè",
            "title": "units",
            "tags": "units, science, measurement, UCUM",
            "published": true,
            "editor": "markdown",
            "date": "2022-08-25T20:07:27.548Z",
            "dateCreated": "2022-07-27T21:23:58.229Z"
          }
        }
      ]
    },
    {
      "name": "regulatory",
      "type": "directory",
      "path": "regulatory",
      "children": [
        {
          "name": "cost-benefit-analysis-framework-for-rational-drug-classification.md",
          "type": "file",
          "path": "regulatory/cost-benefit-analysis-framework-for-rational-drug-classification.md",
          "children": []
        },
        {
          "name": "dfda-executive-order.md",
          "type": "file",
          "path": "regulatory/dfda-executive-order.md",
          "children": [],
          "metadata": {
            "description": "Proposal to transform the FDA into a decentralized, patient-centric platform to accelerate medical innovation and expand access to treatments.",
            "emoji": "üöÄ",
            "title": "Decentralized FDA Transformation Proposal",
            "tags": "FDA, decentralization, medical-innovation, patient-centric, clinical-trials",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:30.544Z",
            "dateCreated": "2025-02-12T20:29:30.544Z"
          }
        },
        {
          "name": "hhs-policy-recommendations.md",
          "type": "file",
          "path": "regulatory/hhs-policy-recommendations.md",
          "children": [],
          "metadata": {
            "title": "HHS Policy Recommendations for Disease Eradication",
            "description": "Proposes a decentralized FDA system that increases trial capacity, reduces costs, and accelerates patient access without legislative changes.",
            "published": true,
            "date": "2025-03-07T00:26:10.239Z",
            "tags": "clinical-trials, decentralized-fda, healthcare-innovation, regulatory-compliance, cost-efficiency",
            "editor": "markdown",
            "dateCreated": "2025-02-20T05:44:49.624Z"
          }
        }
      ]
    },
    {
      "name": "scripts",
      "type": "directory",
      "path": "scripts",
      "children": [
        {
          "name": "README.md",
          "type": "file",
          "path": "scripts/README.md",
          "children": [],
          "metadata": {
            "description": "Automation scripts for repository management including AI-powered file organization and content migration",
            "emoji": "üìÅ",
            "title": "Scripts Directory for Repository Management",
            "tags": "repository-management, automation, ai-powered, file-organization, content-migration",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:36.760Z",
            "dateCreated": "2025-02-12T20:29:36.760Z"
          }
        }
      ]
    },
    {
      "name": "strategy",
      "type": "directory",
      "path": "strategy",
      "children": [
        {
          "name": "implementation-plan.md",
          "type": "file",
          "path": "strategy/implementation-plan.md",
          "children": [],
          "metadata": {
            "description": "Implementation plan for a privacy-preserving system to aggregate treatment reviews and rank treatments by effectiveness.",
            "emoji": "üîí",
            "title": "dFDA Implementation Plan: Privacy-Preserving Treatment Review Aggregation",
            "tags": "dfda, privacy, treatment-reviews, aggregation, implementation-plan",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:46.904Z",
            "dateCreated": "2025-02-12T20:29:46.904Z"
          }
        },
        {
          "name": "patient-industrial-complex.md",
          "type": "file",
          "path": "strategy/patient-industrial-complex.md",
          "children": [],
          "metadata": {
            "description": "A token-based system to incentivize actions that support the Disease Eradication Act and reduce patient suffering",
            "emoji": "üèõÔ∏è",
            "title": "Patient Industrial Complex Advocacy System",
            "tags": "patient-industrial-complex, tokens, advocacy, disease-eradication-act",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:50.146Z",
            "dateCreated": "2025-02-12T20:29:50.146Z"
          }
        },
        {
          "name": "roadmap.md",
          "type": "file",
          "path": "strategy/roadmap.md",
          "children": [],
          "metadata": {
            "description": "A comprehensive to-do list for launching a global decentralized trial system with AI coordination, focusing on patient rights and universal data-sharing standards.",
            "emoji": "‚öôÔ∏è",
            "title": "Roadmap to a Global Autonomous Decentralized FDA",
            "tags": "decentralized-fda, clinical-trials, ai-coordination, patient-rights, data-sharing-standards",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:53.772Z",
            "dateCreated": "2025-02-12T20:29:53.772Z"
          }
        },
        {
          "name": "strategy-comparison.md",
          "type": "file",
          "path": "strategy/strategy-comparison.md",
          "children": [],
          "metadata": {
            "description": "An exhaustive strategy comparison document for creating a global autonomous decentralized FDA, addressing regulatory, legal, and policy barriers.",
            "emoji": "üåê",
            "title": "Strategies for Global Autonomous Decentralized FDA",
            "tags": "decentralized-fda, global-system, regulatory-barriers, legal-frameworks, patient-rights",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T20:29:57.164Z",
            "dateCreated": "2025-02-12T20:29:57.164Z"
          }
        },
        {
          "name": "war-on-disease-strategy.md",
          "type": "file",
          "path": "strategy/war-on-disease-strategy.md",
          "children": [],
          "metadata": {
            "description": "A high-level strategy for eradicating disease through restructured institutional frameworks and financial incentives",
            "emoji": "‚öîÔ∏è",
            "title": "High-Level Strategy for War on Disease",
            "tags": "disease-eradication, healthcare-reform, decentralized-FDA, clinical-trials, policy",
            "published": true,
            "editor": "markdown",
            "date": "2025-02-12T16:56:18.388Z",
            "dateCreated": "2025-02-12T16:56:18.388Z"
          }
        }
      ]
    },
    {
      "name": "wiki",
      "type": "directory",
      "path": "wiki",
      "children": [
        {
          "name": "interventions",
          "type": "directory",
          "path": "wiki/interventions",
          "children": [
            {
              "name": "brain-computer-interfaces-for-depression.md",
              "type": "file",
              "path": "wiki/interventions/brain-computer-interfaces-for-depression.md",
              "children": [],
              "metadata": {
                "title": "Brain Computer Interfaces For Depression",
                "description": "Volume knobs for mood",
                "published": true,
                "date": "2023-05-27T23:24:24.846Z",
                "tags": "depression, brain computer interfaces",
                "editor": "markdown",
                "dateCreated": "2023-05-27T23:24:24.846Z"
              }
            }
          ]
        }
      ]
    }
  ]
} as const;

// Type definition for the tree structure
export type TreeNode = {
    name: string;
    type: 'file' | 'directory';
    path: string; // Relative path with forward slashes
    metadata?: Record<string, any>;
    children: TreeNode[];
};
